Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,G protein-coupled receptor binding (GO:0001664),0.5910278135704705,1.9331602460533794,0.0,0.2883528520654897,0.228,11/132,4.96%,PTCH1;GNA14;ITGB4;PTCH2;HOMER2;WNT10A;WNT2B;WNT16;GNAQ;UTS2B;WNT5A
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.757167831027882,-1.920201931750265,0.0,0.17355085039916696,0.127,5/12,3.56%,IGF1;INSR;GNAS;PIK3R1;IGF2
prerank,sterol binding (GO:0032934),0.6514405512643611,1.901346065204871,0.0013774104683195593,0.2426731923323428,0.344,5/56,0.67%,PTCH1;RORA;APOD;CAV1;VDAC2
prerank,cholesterol binding (GO:0015485),0.6410926505851683,1.821844660790694,0.00425531914893617,0.5310260443978325,0.731,4/47,0.67%,PTCH1;APOD;CAV1;VDAC2
prerank,wide pore channel activity (GO:0022829),-0.5823456735355912,-1.795697593205253,0.008174386920980926,0.41081024081828127,0.462,4/23,2.70%,GJB6;GJC1;GJD3;GJA1
prerank,gap junction channel activity (GO:0005243),-0.5899277535325174,-1.7949781575513928,0.002785515320334262,0.27680262215563334,0.465,4/22,2.70%,GJB6;GJC1;GJD3;GJA1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.6932242389967586,-1.784421695989924,0.00234192037470726,0.23753399619506238,0.509,4/13,1.14%,PDGFD;IL1R1;PDGFRB;PDGFRA
prerank,death receptor binding (GO:0005123),0.7932419359980669,1.780630639741364,0.006688963210702341,0.6402289809473868,0.869,2/15,0.24%,NGF;EDA
prerank,receptor antagonist activity (GO:0048019),0.7348704722671577,1.7528958790910985,0.013266998341625208,0.6806269300238886,0.938,2/17,0.99%,PXDN;DKKL1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6519095244923234,1.7479367929869933,0.01337295690936107,0.5974836049123762,0.945,10/35,8.36%,PKDCC;TEC;ITK;CLK1;TXK;PEAK1;SRC;FER;ABL2;DYRK1A
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.7155471756688605,-1.7331984335647483,0.014814814814814815,0.3224970232733887,0.695,4/11,15.14%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.7339499006800785,-1.7331870420959454,0.002304147465437788,0.2687475193944906,0.695,4/10,8.23%,SLCO3A1;SLCO1C1;SLC22A6;SLCO2A1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7085694691146351,-1.6984634567061407,0.0045351473922902496,0.32905617837889073,0.822,5/10,13.44%,SHANK3;GNAS;SQSTM1;IGSF11;SHANK2
prerank,insulin-like growth factor I binding (GO:0031994),0.7458649522235015,1.664692696215551,0.018456375838926176,1.0,1.0,3/13,0.32%,ITGB4;ITGA6;IGFBP6
prerank,insulin-like growth factor binding (GO:0005520),0.7248710129476568,1.6643644416073875,0.0214168039538715,0.9737856629571364,1.0,3/15,0.32%,ITGB4;ITGA6;IGFBP6
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.5715934057923925,-1.637133767627048,0.017326732673267328,0.5018420555450595,0.95,6/18,2.84%,ENG;SMAD3;SMAD6;TGFBR3;FKBP1A;TGFBR1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.5144897956341428,-1.6148303250082354,0.02476780185758514,0.5316367822354229,0.981,10/27,9.89%,SLC22A8;SLC26A7;ANO1;SLC39A8;SLC22A6;SLC26A2;SLC39A14;SLC25A30;SLC25A11;LRRC8A
prerank,neuropeptide receptor activity (GO:0008188),0.6215350853088506,1.6085252134843315,0.023564064801178203,1.0,1.0,3/29,2.77%,SORCS2;SSTR1;KISS1R
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7250606090534113,1.6070428933413254,0.034129692832764506,1.0,1.0,2/14,2.53%,RDH10;RDH5
prerank,actinin binding (GO:0042805),0.6301826026060681,1.5876769605820125,0.04113924050632911,1.0,1.0,6/21,7.46%,MAGI1;KCNA5;PDLIM4;CSRP3;DAG1;RARA
prerank,CoA-ligase activity (GO:0016405),-0.5992742282566536,-1.5870178979923169,0.031496062992125984,0.6007275954639519,0.988,5/14,20.86%,ACSL1;ACSS3;ACSS1;AACS;SLC27A2
prerank,calcium-release channel activity (GO:0015278),0.6645524896027364,1.5867713159149304,0.051364365971107544,1.0,1.0,4/17,3.58%,ITPR2;ITPR3;TPCN1;FKBP1B
prerank,voltage-gated ion channel activity (GO:0005244),0.690486608830148,1.5825560199184279,0.04666666666666667,1.0,1.0,3/14,4.79%,VDAC2;ANO6;CACNA1H
prerank,lipoprotein particle receptor binding (GO:0070325),-0.4928392563813323,-1.5554906270135298,0.01977401129943503,0.6938039750134707,0.998,8/27,13.61%,PICALM;LRP1;AP2A1;APOE;DNAJA1;LDLRAP1;ANKRA2;MESD
prerank,O-acyltransferase activity (GO:0008374),0.5949022955242926,1.5514167967520067,0.036753445635528334,1.0,1.0,6/30,7.22%,MBOAT2;MOGAT2;MOGAT3;GPAT3;AWAT2;SOAT1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.3989253009861199,-1.5493811673961502,0.005405405405405406,0.6662851477086161,0.998,23/72,9.31%,PLCB1;PICALM;HIP1;PARD3;SVIL;ADAP2;MYO1B;ACTN2;MARK1;KCNJ2;GSDME;COMMD1;SNX21;ANXA2;SYT7;HIP1R;TWF1;RPH3A;FRMPD4;TULP3;LDLRAP1;SLC9A1;CAPG
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7140858919442538,1.5388059854969511,0.06583629893238434,1.0,1.0,2/11,3.04%,ROR2;STK38
prerank,growth factor activity (GO:0008083),0.5035065050341098,1.5326075492111313,0.03209242618741977,1.0,1.0,4/74,2.29%,NGF;FGF7;FGF1;JAG1
prerank,GABA receptor binding (GO:0050811),-0.6122876616960228,-1.5316738129465526,0.05303030303030303,0.701638881068492,0.998,4/11,17.93%,ARFGEF2;GABARAPL1;GABARAP;LHFPL4
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5953626050471258,-1.5313125985243268,0.046189376443418015,0.6528556176182044,0.998,5/12,20.33%,SLC6A6;SLC38A7;SLC3A2;SLC38A5;SLC1A4
prerank,kinase activator activity (GO:0019209),-0.47278936721272175,-1.5181334318061195,0.040625,0.6643995213804396,0.999,13/30,27.59%,PRKAG2;MADD;GPRC5C;BCL10;RPLP1;CDK5R1;GPRC5B;WNT11;GPRC5A;NCKAP1L;WNK1;AGAP2;TPX2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6664764962880052,1.5174957739579518,0.07457627118644068,1.0,1.0,7/14,18.82%,MINDY3;MINDY2;USP13;OTUD7B;MINDY4;USP15;USP9X
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6613504627207071,1.5171388437404016,0.06602254428341385,1.0,1.0,7/16,15.79%,MTMR7;MTMR6;INPP5F;MTMR3;PTEN;MTMR12;MTMR1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.48361437966653625,-1.5169180476349382,0.032640949554896145,0.6269249864893959,0.999,9/26,12.98%,SLC16A12;SLC6A6;ABCG2;SLC5A6;SLC16A6;SLC16A4;SLC16A2;SLC16A7;SLC6A1
prerank,tropomyosin binding (GO:0005523),0.6463280674591161,1.5169164087409008,0.06504065040650407,1.0,1.0,6/16,9.26%,SMTNL1;SMTNL2;TMOD2;S100A6;TMOD1;CALD1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.4211646052361686,-1.512221730810969,0.0234375,0.6089140782433914,0.999,20/47,24.62%,SLC7A11;SLC6A6;SLC47A1;SLC7A5;SLC22A4;SLC7A1;SLC38A11;SLC7A6;SLC43A2;SLC16A2;SLC6A1;SLC38A7;SLC3A2;SLC22A2;SLC38A5;SLC25A29;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4979314319880393,-1.5093853046492198,0.05319148936170213,0.5867410079423313,1.0,10/23,15.52%,PDE7B;PDE5A;PDE8A;PDE8B;PDE1A;PDE10A;PDE2A;CNP;PDE4A;PDE1B
prerank,alpha-actinin binding (GO:0051393),0.5991968415696027,1.507756893006848,0.05864197530864197,1.0,1.0,5/24,7.46%,MAGI1;KCNA5;PDLIM4;DAG1;RARA
prerank,syntaxin binding (GO:0019905),-0.39703013719515845,-1.4999164450210636,0.012048192771084338,0.5925125468824325,1.0,22/61,21.83%,DAPK1;UNC13C;STXBP3;NAPA;TMED9;STX8;SYT9;LRRK2;RAB11A;GOLGA2;SYPL1;SYNPR;STX6;SCFD1;STXBP4;CPLX2;STX16;BLOC1S6;UNC13A;SNAP47;SYT6;SNAP25
prerank,protein tyrosine kinase activity (GO:0004713),0.46825275981891834,1.4961335673221248,0.02702702702702703,1.0,1.0,18/108,6.49%,ROR2;PKDCC;ROR1;TEC;NTRK3;FGFR1;EGFR;MUSK;ITK;CLK1;WEE1;TXK;PEAK1;SRC;HIPK1;FER;EPHB2;ABL2
prerank,mechanosensitive ion channel activity (GO:0008381),0.6682767954402169,1.4949678898164016,0.06228956228956229,1.0,1.0,5/12,14.45%,PIEZO2;TMC2;PIEZO1;TMC4;TMEM63A
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6210536163833441,-1.4902772313193602,0.04821802935010482,0.6000685416016767,1.0,6/10,17.69%,CASP3;CFLAR;CASP12;CASP6;CASP8;CASP4
prerank,I-SMAD binding (GO:0070411),-0.5730730168410946,-1.4901845667768918,0.0611764705882353,0.5719122960411367,1.0,5/13,4.13%,SMAD3;SMAD6;SMAD9;TGFBR1;SMAD5
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.5055834471020728,-1.4874888416217624,0.049738219895287955,0.5564012303936469,1.0,9/22,21.63%,PICALM;AP2A1;APOE;DNAJA1;LDLRAP1;ANKRA2;MESD;APBB3;CLU
prerank,transforming growth factor beta binding (GO:0050431),-0.4924451204808796,-1.4867592826519216,0.045454545454545456,0.5343112037055257,1.0,7/23,8.48%,ENG;TGFBR3;TGFBR1;ACVRL1;NRROS;TGFB3;VASN
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.6053341692402855,1.4867472672427677,0.08722741433021806,1.0,1.0,14/20,30.68%,USP50;UFSP2;USP47;COPS5;USP9X;SENP3;SENP2;OTUB1;SENP5;SENP1;DESI2;OTULINL;OTUD5;EIF3H
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.601595319722401,-1.4862503225149644,0.056842105263157895,0.5135585686521762,1.0,8/11,27.94%,CASP3;CFLAR;CASP12;CASP6;CASP8;CASP4;PYCARD;CASP1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.35705454580674295,-1.4803740877286866,0.017964071856287425,0.5111182386565846,1.0,25/91,9.31%,PLCB1;PICALM;HIP1;PARD3;SVIL;ADAP2;MYO1B;ACTN2;MARK1;KCNJ2;GSDME;COMMD1;SNX21;ANXA2;SYT7;KCNH1;HIP1R;TWF1;RPH3A;FRMPD4;TULP3;WIPI1;LDLRAP1;SLC9A1;CAPG
prerank,ephrin receptor binding (GO:0046875),0.6041662876566238,1.4780700561697526,0.07009345794392523,1.0,1.0,8/21,16.82%,EFNA5;EFNB1;SRC;EFNB2;ANKS1B;ANKS1A;EFNA3;EFNB3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5915760431246682,-1.4773099226643753,0.06601466992665037,0.5021483466028478,1.0,8/12,26.21%,SDHB;XDH;AOX1;CIAPIN1;FXN;ISCA2;ISCU;CISD2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5850668029385694,-1.4756491259938287,0.0776255707762557,0.48831009314139734,1.0,5/12,3.88%,ENG;TGFBR3;TGFBR1;ACVRL1;BMPR2
prerank,peptidase activator activity (GO:0016504),0.5907417702501503,1.4744998351793748,0.07541478129713423,1.0,1.0,5/22,8.38%,CAV1;APH1B;PSME3;NLRC4;EBAG9
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5290212662906836,1.4666302703717993,0.06420765027322405,1.0,1.0,2/42,0.08%,STXBP6;NTNG1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.609131048011229,1.4655992942959295,0.07933884297520662,1.0,1.0,1/18,0.06%,STXBP6
prerank,ATPase binding (GO:0051117),0.4824000303755409,1.4649151152862907,0.05555555555555555,1.0,1.0,19/71,10.71%,CAV1;EGFR;SLC2A13;SLC26A9;NUFIP1;PDE4D;PGR;SRC;NCSTN;SELENOS;RDX;SNX10;ALDOB;ATP6V0A1;SNU13;ATP1B3;ABCA1;CHMP4A;ANK1
prerank,aminopeptidase activity (GO:0004177),0.57086659731658,1.4595517559434887,0.0744047619047619,1.0,1.0,10/26,12.55%,XPNPEP2;MMP15;RNPEP;LVRN;BLMH;LNPEP;XPNPEP3;KDM8;MMP16;LTA4H
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5836307044801612,1.4538651939618927,0.08841463414634146,1.0,1.0,3/21,8.47%,FGF7;FGF1;FGF18
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.6463956276197491,1.4521251719631871,0.09283387622149837,1.0,1.0,6/14,15.79%,MTMR7;MTMR6;MTMR3;PTEN;MTMR12;MTMR1
prerank,metalloaminopeptidase activity (GO:0070006),0.6235613730002393,1.4513594611892862,0.09807073954983923,1.0,1.0,10/16,21.77%,MMP15;RNPEP;LVRN;LNPEP;XPNPEP3;MMP16;LTA4H;MMP14;ENPEP;XPNPEP1
prerank,gated channel activity (GO:0022836),0.6267574107031689,1.448196611963005,0.087893864013267,1.0,1.0,6/14,15.50%,PIEZO2;TMC2;PIEZO1;TMC4;TMEM63A;TMEM266
prerank,voltage-gated anion channel activity (GO:0008308),0.6329355794259981,1.4478001643763512,0.08267090620031796,0.9933646592704553,1.0,4/15,6.18%,VDAC2;ANO6;CLCN2;CLCN1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.48934038133426433,-1.4476718364145416,0.07329842931937172,0.5617257294000162,1.0,9/21,15.52%,PDE7B;PDE5A;PDE8A;PDE8B;PDE1A;PDE10A;PDE2A;PDE4A;PDE1B
prerank,mannose binding (GO:0005537),0.6308872513019889,1.4394863271473053,0.10683012259194395,1.0,1.0,2/12,3.61%,COLEC11;LMAN2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5170366772916829,-1.439338536197296,0.07235142118863049,0.5692861810343691,1.0,5/18,3.88%,ENG;TGFBR3;TGFBR1;ACVRL1;BMPR2
prerank,peptide hormone receptor binding (GO:0051428),0.6627765503959753,1.436125904625078,0.11867364746945899,1.0,1.0,2/11,4.00%,GNRH1;PTHLH
prerank,retinoic acid binding (GO:0001972),0.641249675318114,1.4345064537109171,0.11449016100178891,0.9812639068014002,1.0,2/12,7.46%,NR2F2;RARA
prerank,transcription coactivator binding (GO:0001223),0.5791448751553059,1.4336118313624708,0.10063897763578275,0.9600492082621632,1.0,3/20,4.11%,RORA;VGLL4;PGR
prerank,carbohydrate kinase activity (GO:0019200),0.6650817138505772,1.432247307144835,0.10135135135135136,0.9425578079659533,1.0,6/11,16.91%,HK2;NAGK;GALK1;GALK2;FGGY;POMK
prerank,amyloid-beta binding (GO:0001540),-0.3588951956681317,-1.4299240735751746,0.03,0.5831162116998172,1.0,17/79,12.75%,PICALM;INSR;ITM2A;COL25A1;FZD6;LRP1;EPHA4;GRIA2;LDLR;GRIN2B;APOE;APBB2;LDLRAP1;GRIN1;VBP1;CRYAB;TGFB2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5309694992911826,-1.424841491137417,0.08611111111111111,0.5814555849429012,1.0,7/14,23.73%,SDHB;NFU1;CIAO3;ISCA2;RSAD2;ISCU;EXO5
prerank,clathrin adaptor activity (GO:0035615),-0.5178711299353762,-1.421666824473951,0.07913669064748201,0.5739947231754093,1.0,5/15,8.47%,HIP1;DAB2;AP2A1;HIP1R;LDLRAP1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5927840524756353,1.4114681489055856,0.09891808346213292,1.0,1.0,2/18,2.53%,HSD17B3;RDH5
prerank,hexosaminidase activity (GO:0015929),0.6393981856352529,1.41025793154265,0.13253012048192772,1.0,1.0,6/12,20.32%,NAGA;HEXA;CEMIP2;HEXB;OGA;CEMIP
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.5917369854168482,-1.4083094997246908,0.09069767441860466,0.6010038655173299,1.0,4/10,11.33%,NOX4;CYBA;NOX1;NCF2
prerank,androgen receptor binding (GO:0050681),-0.45672797287445044,-1.4063806997130675,0.08683473389355742,0.5899178198601617,1.0,7/25,13.08%,FOXP1;EP300;WIPI1;RNF6;SNW1;KDM1A;ARID5A
prerank,histone acetyltransferase binding (GO:0035035),-0.4768690337547932,-1.4008936123563323,0.07736389684813753,0.5910771639092062,1.0,5/21,10.59%,GLI3;HIF1A;MEF2A;CITED2;EPAS1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6482984337170579,1.3994871080434852,0.13612565445026178,1.0,1.0,4/10,14.78%,DPYS;CAD;DPYSL2;DPYSL5
prerank,protein kinase activator activity (GO:0030295),-0.3726772098822874,-1.3963892821896113,0.03982300884955752,0.5895480892075781,1.0,26/60,28.39%,PRKAG2;FAM20A;AFAP1L2;IGF2;MADD;GPRC5C;CALM1;MAP2K2;ABI1;RPLP1;RICTOR;CALM3;CDK5R1;GPRC5B;WNT11;CD24;GPRC5A;NCKAP1L;MAP2K1;ERBB3;WNK1;AGAP2;MLST8;TPX2;DDX3X;PARP16
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3888688394209398,1.3925794767994308,0.0,1.0,1.0,85/731,8.29%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;ZSCAN25;BHLHE22;ZBTB20;NEUROD6;RUNX2;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;ZKSCAN7;KLF3;CIART;SPI1;FOXK1;ZNF418;FOXO3;SOX9;PGR;FOXP4;NPAS2;GLIS2;ZNF585B;ZNF585A;HDAC4;REL;CHD2;SATB1;ZBTB3;KLF10;POU5F2;CREB3L1;HEYL;ZNF697;ZFP1;SP3;BHLHE40;ONECUT1;NRIP1;ZFP14;TEAD3;CTCF;NFE2L1;NRF1;HIC1;ZNF431;PAX3;HOXC10;ZFP62;TBX2;ONECUT3;RREB1;RARA;MAFG;USF2;MYPOP;PKNOX2;ZNF628;E4F1;FOXK2
prerank,alpha-tubulin binding (GO:0043014),0.5242258242657517,1.3923923775459315,0.12406576980568013,1.0,1.0,11/31,18.20%,DLEC1;TRPV4;RACGAP1;SPAST;FNTA;HDAC6;INO80;ARL8B;TBCE;SETD2;OFD1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5671457602176521,1.391590878331606,0.11058451816745656,1.0,1.0,5/21,18.62%,CHRNB3;GRIA1;GRM1;CHRNA7;CHRFAM7A
prerank,NADP binding (GO:0050661),-0.41763277607248306,-1.3907462203704375,0.06140350877192982,0.5924953596076932,1.0,15/32,23.37%,DPYD;NOS3;CRYZL1;CAT;NOX1;QDPR;ME1;DHFR;MTRR;PGD;NOS1;DHCR7;CRYZ;ME3;TM7SF2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4681071246724638,1.39058312379301,0.08672798948751642,0.9862089580974239,1.0,8/60,2.13%,ROR2;ROR1;NTRK3;FGFR1;EFEMP1;EGFR;MUSK;NRP2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3875823071526202,1.3874980280037401,0.0,0.9799461401175132,1.0,85/732,8.29%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;ZSCAN25;BHLHE22;ZBTB20;NEUROD6;RUNX2;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;ZKSCAN7;KLF3;CIART;SPI1;FOXK1;ZNF418;FOXO3;SOX9;PGR;FOXP4;NPAS2;GLIS2;ZNF585B;ZNF585A;HDAC4;REL;CHD2;SATB1;ZBTB3;KLF10;POU5F2;HEYL;ZNF697;ZFP1;SP3;BHLHE40;ONECUT1;NRIP1;ZFP14;TEAD3;CTCF;NFE2L1;NRF1;HIC1;ZNF431;PAX3;HOXC10;ZFP62;TBX2;ONECUT3;RREB1;RARA;MAFG;USF2;MYPOP;ISL1;PKNOX2;ZNF628;E4F1;FOXK2
prerank,transcription corepressor binding (GO:0001222),0.5433718428490335,1.386653895374908,0.1056782334384858,0.9631191451895874,1.0,1/27,0.04%,RORA
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5076945425510397,1.3847812603189718,0.09970674486803519,0.9527860319679933,1.0,12/38,12.61%,SORBS1;RGS14;AXIN1;CD3G;NUP62;CARD10;TRADD;NCK2;GAB2;LAT;SPAG9;SH2B1
prerank,GTPase inhibitor activity (GO:0005095),-0.5285836299367317,-1.3814573287577023,0.11809045226130653,0.6081506231758951,1.0,7/13,19.54%,SLIT2;TNK2;CPEB2;IQGAP2;RHOH;ARL2;GPS1
prerank,Wnt-activated receptor activity (GO:0042813),0.5929928166505543,1.377892923277065,0.13747954173486088,0.9655347744178369,1.0,6/15,14.91%,ROR1;FZD2;PKD1;FZD7;FZD9;FZD3
prerank,beta-tubulin binding (GO:0048487),0.5212120401046186,1.374265556931174,0.1223021582733813,0.9628369128148063,1.0,9/31,13.97%,DLEC1;TRPV4;RACGAP1;SMC3;SPAST;IFT74;ARL8B;EMD;HTT
prerank,acid-thiol ligase activity (GO:0016878),-0.5234219995389209,-1.372705837581732,0.11678832116788321,0.6203555713878695,1.0,5/13,20.86%,ACSL1;ACSS3;ACSS1;AACS;SLC27A2
prerank,LRR domain binding (GO:0030275),-0.5151103892556429,-1.3699072690204859,0.11267605633802817,0.6133594611575621,1.0,7/14,19.54%,ROBO1;PAWR;LRRFIP2;ZXDC;ATF4;POLR2J;DAPK3
prerank,death receptor activity (GO:0005035),-0.5599668404043208,-1.3661966358803521,0.12373737373737374,0.6091961696861157,1.0,4/11,13.49%,TNFRSF19;FAS;TNFRSF1B;TNFRSF11A
prerank,syntaxin-1 binding (GO:0017075),-0.4582014096848136,-1.3652252845412098,0.09970674486803519,0.5977513919112959,1.0,9/22,21.83%,DAPK1;UNC13C;STXBP3;LRRK2;SYPL1;SYNPR;CPLX2;UNC13A;SNAP25
prerank,phosphatase activator activity (GO:0019211),-0.5072547804575153,-1.363243291899025,0.12403100775193798,0.5901341986931933,1.0,9/14,32.61%,FRS2;CALM1;BMP2;CALM3;PPP2R5A;PPP2R5E;PPP2R5D;PPP1R15A;B3GAT3
prerank,pyrophosphatase activity (GO:0016462),-0.37649138361682233,-1.3624420356462486,0.08029197080291971,0.5791435814744353,1.0,32/50,39.36%,ENPP1;ENTPD1;ENPP3;ALPL;PLPP1;NUDT3;LHPP;ENTPD5;TRPM2;PPA1;PLPP4;ENTPD3;NUDT11;DHX29;CILP;DCP2;FITM2;NUDT16;NUDT16L1;CILP2;NUDT22;DDX3X;BNIPL;ENTPD6;PRUNE1;NUDT10;ATCAY;RNGTT;DCTPP1;NUDT14;PLPP5;PRUNE2
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.45381390709273095,-1.3602806486774792,0.1069364161849711,0.5724004840872666,1.0,10/21,30.95%,ARFGEF2;WASF3;AKAP6;AKAP1;PJA2;AKAP8L;AKAP7;ACBD3;KCNQ1;RYR2
prerank,receptor ligand activity (GO:0048018),0.39485936439849945,1.3576788203029615,0.046413502109704644,1.0,1.0,28/245,10.21%,NGF;EDA;FGF7;INHBB;IL19;WNT10A;FGF1;JAG1;SEMA4B;INSL6;WNT2B;GNRH1;IL1A;WNT16;PTHLH;NBL1;BMP5;WNT5A;BMP15;APLN;ARTN;SEMA3A;DPP4;FGF18;TAFA5;HMGB1;LEFTY1;C1QTNF12
prerank,protein phosphatase 1 binding (GO:0008157),0.5477769433004807,1.3522634176148964,0.14446227929373998,1.0,1.0,4/21,6.22%,SMTNL1;SH3RF2;SMTNL2;AKAP11
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5899423602140228,1.3518575896392155,0.16220735785953178,1.0,1.0,1/13,0.72%,EHHADH
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.6087577640034061,1.3516059494798294,0.15798045602605862,0.9957127647741176,1.0,6/15,11.05%,PHLDA3;SESTD1;LANCL2;SH3PXD2B;OBSCN;SAP30L
prerank,enoyl-CoA hydratase activity (GO:0004300),0.638240817218759,1.3501707463465866,0.1616871704745167,0.9847127541805046,1.0,3/10,7.98%,EHHADH;HADHB;HSD17B4
prerank,solute:proton symporter activity (GO:0015295),-0.49500911767529937,-1.3496380666595895,0.14460784313725492,0.5924798706802602,1.0,8/16,10.34%,SLC39A8;SLC17A5;SLC15A2;SLC11A2;SLC15A4;SLC33A1;SLC2A10;CTNS
prerank,retinoid binding (GO:0005501),-0.4630327300759495,-1.345717193884627,0.10540540540540541,0.5914424146312575,1.0,6/22,10.08%,ALDH1A2;RBP1;CYP26B1;RBP4;ABCA4;PTGDS
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5610237092342079,-1.3429176181995788,0.12413793103448276,0.5871758004209157,1.0,2/10,1.72%,PRKAG2;PKIG
prerank,tau protein binding (GO:0048156),-0.38868508979255695,-1.341839491354676,0.09252669039145907,0.5786448077181215,1.0,10/40,12.54%,PICALM;ROCK2;MARK1;EP300;APOE;ACTB;LGMN;GSK3A;TTBK1;TAOK2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5765339676773096,1.341321480844817,0.1746880570409982,1.0,1.0,8/13,24.56%,TARBP1;WDR4;FTSJ1;TRMT5;THUMPD3;TRMT1L;TRMT1;THUMPD2
prerank,telomerase RNA binding (GO:0070034),0.5357966642329475,1.3392162897527427,0.16512345679012347,0.9981596336947766,1.0,6/22,12.93%,HNRNPC;NAF1;WRAP53;EXOSC10;TEP1;SMG7
prerank,acetylcholine receptor activity (GO:0015464),0.5384987948527138,1.337716772811624,0.14285714285714285,0.9875968242023719,1.0,5/22,18.62%,CHRNB3;CHRM2;CHRM3;CHRNA7;CHRFAM7A
prerank,endopeptidase inhibitor activity (GO:0004866),0.4350831256450965,1.3364464594292207,0.08776266996291718,0.977116471479345,1.0,4/82,1.58%,NGF;SPINK1;SERPINB2;SERPING1
prerank,peptidase inhibitor activity (GO:0030414),0.4969710940032677,1.3361412527811065,0.14556040756914118,0.9624866555931572,1.0,2/33,0.61%,GPC3;SPINK1
prerank,serine-type endopeptidase activity (GO:0004252),0.43352649603269794,1.3343014159252615,0.11056511056511056,0.954437809767072,1.0,16/80,17.96%,CORIN;CTRC;FAP;KLK2;PCSK5;CD5L;DPP4;PCSK7;PROC;CELA1;HTRA2;PLG;TYSND1;MBTPS1;MASP2;RHBDF1
prerank,sequence-specific DNA binding (GO:0043565),0.3741722272336375,1.3325146180488252,0.006036217303822937,0.9470976540836122,1.0,81/590,11.82%,RORA;MEOX2;KLF5;ETV4;NFATC2;ETV1;PPARGC1A;PAX9;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;BHLHE22;ZBTB20;MYBBP1A;ETV5;RUNX2;HOXB6;GLI2;TEF;HLX;KLF3;KMT2A;FOXK1;FOXO3;SOX9;NPAS2;GLIS2;HDAC4;SATB1;KLF10;CREB3L1;ZFP1;SP3;BHLHE40;STN1;ONECUT1;SIRT3;CTCF;HIC1;PAX3;HOXC10;TBX2;ONECUT3;RARA;MAFG;USF2;LHX6;ISL1;PKNOX2;FOXK2;UPF2;LIN28B;TBX18;TET1;SLTM;MECP2;RORB;POU4F1;HDAC2;DBP;TLX3;TFEB;LONP1;MMP12;RARG;FBXL19;EN2;EGR1;ZBTB49;ZNF148;ERF
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5725169366599526,1.3266272360705573,0.16071428571428573,0.9579345831148401,1.0,2/15,1.67%,ALDH1A3;ALDH9A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5521308307922287,-1.3253072604214147,0.1479028697571744,0.6165888250827112,1.0,8/10,40.88%,LACC1;CDA;GDA;ADA;DCTD;ADARB2;CDADC1;APOBEC1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6101838310602353,1.323598870271188,0.16520210896309315,0.95534908875234,1.0,2/11,5.38%,ARG1;DDAH2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6353513685808064,1.3209640884525775,0.19818181818181818,0.9521930839008274,1.0,1/10,0.29%,CXADR
prerank,phosphatase binding (GO:0019902),0.4193024680740003,1.3174621020784127,0.10295857988165681,0.9536339163009169,1.0,20/105,10.73%,NFATC2;PXN;CEACAM1;EGFR;PDLIM4;SH3RF2;CDH5;SPRED1;EIF2AK3;SFI1;MAP3K5;PIK3R2;ELL;ANAPC5;MTMR3;ANAPC7;PTPRT;DLG3;ANK1;TRPC4AP
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5381278037415094,1.312390965614048,0.1648854961832061,0.9594407943215741,1.0,4/20,3.57%,MPP1;CASK;TJP2;MAGI3
prerank,alkali metal ion binding (GO:0031420),0.5783829380627734,1.312216576993117,0.1695501730103806,0.9463358010054771,1.0,4/13,7.77%,TDG;HDAC4;ATP1A2;ACAT1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.36622742860109175,1.3112933326365075,0.003009027081243731,0.9365553807609392,1.0,90/831,8.29%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;ZSCAN25;BHLHE22;ZBTB20;NPAS3;NEUROD6;ETV5;RUNX2;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;ZKSCAN7;KLF3;CIART;SPI1;FOXK1;ZNF418;FOXO3;SOX9;PGR;FOXP4;NPAS2;ZBTB8A;GLIS2;ZNF585B;ZNF585A;HDAC4;REL;CHD2;SATB1;ZBTB3;KLF10;POU5F2;HEYL;ZFP3;ZNF697;ZFP1;SP3;BHLHE40;ZFP90;ONECUT1;NRIP1;ZFP14;TEAD3;CTCF;NFE2L1;NRF1;HIC1;ZNF431;PAX3;HOXC10;ZFP62;TBX2;ONECUT3;RREB1;RARA;MAFG;USF2;LHX6;MYPOP;PKNOX2;ZNF628;E4F1;FOXK2
prerank,cGMP binding (GO:0030553),-0.529582824946895,-1.3094173618502503,0.1595238095238095,0.6549832354789112,1.0,4/11,9.40%,RAPGEF2;PDE5A;PDE10A;PDE2A
prerank,antiporter activity (GO:0015297),0.5432157878296877,1.3082404884107808,0.168,0.9360711258168365,1.0,4/20,8.08%,SLC35A1;SLC35D3;SLC35C2;SLC35D2
prerank,myosin II binding (GO:0045159),-0.5370215579941399,-1.3069370529497664,0.16933638443935928,0.6497806364567642,1.0,5/10,28.08%,TRIOBP;LLGL2;MYL4;SHROOM1;STXBP5
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.4567025803914768,1.3041224346137454,0.1411451398135819,0.9397109630751769,1.0,8/48,8.00%,PIEZO2;NALCN;TRPM3;SLC12A2;TRPV4;SLC12A4;SLC4A11;PIEZO1
prerank,SH2 domain binding (GO:0042169),0.4879337202115659,1.301471472582722,0.16789396170839468,0.938232052224481,1.0,6/31,7.06%,DLC1;TRPV4;SRC;NUP62;SH3PXD2B;DAG1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.35516848461962525,-1.2995171625413877,0.06578947368421052,0.661292158411347,1.0,13/55,13.08%,SLC16A12;SLC13A3;SLC6A6;SLC7A5;SLC22A4;SLC7A1;SLC38A11;SLC7A6;SLC16A6;SLC16A4;SLC16A2;SLC16A7;SLC38A7
prerank,platelet-derived growth factor binding (GO:0048407),-0.5376882385344514,-1.2986071749479953,0.1549636803874092,0.6519954767750232,1.0,3/11,1.97%,PDGFRB;PDGFRA;COL5A1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.4514631494182259,-1.2958775100105915,0.15885416666666666,0.6368892532166536,1.0,7/17,18.50%,EPHA7;EPHA3;EPHA4;EPHA8;EPHA10;EPHB3;EPHB1
prerank,ephrin receptor activity (GO:0005003),-0.4514631494182259,-1.2958775100105915,0.15885416666666666,0.6368892532166536,1.0,7/17,18.50%,EPHA7;EPHA3;EPHA4;EPHA8;EPHA10;EPHB3;EPHB1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.39679915647581543,-1.2945227965169521,0.13468013468013468,0.6299552853152085,1.0,7/30,6.86%,SLC30A10;SLC39A10;SLC39A8;ATP7A;SLC31A1;SLC11A2;SLC39A14
prerank,cytokine receptor activity (GO:0004896),-0.3235915885777053,-1.293989443618853,0.06735751295336788,0.6206279919719664,1.0,14/83,8.25%,IL1R1;OSMR;IL31RA;GHR;IL13RA1;IL6R;IFNAR2;IL1RAP;IL10RB;F3;LIFR;CNTFR;IL15RA;CMKLR1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.35825444088045366,-1.291592633566726,0.1037037037037037,0.6173696363534408,1.0,9/49,7.39%,ANXA3;DYSF;C2CD5;SYT9;ANXA2;SYT7;RPH3A;MCTP2;ANXA1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5632312008264986,1.2899352911840714,0.19205298013245034,0.9739464162641929,1.0,1/14,0.03%,NGF
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.4920805256987887,-1.2895784771296066,0.17633410672853828,0.6129383989677751,1.0,6/14,25.01%,NOX4;CYBA;NOX1;NCF2;AIFM1;KMO
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5095942954717272,-1.2869509252850173,0.18271604938271604,0.6103991208581616,1.0,10/12,28.18%,PDE7B;PDE8A;PDE8B;PDE2A;PDE4A;PDE1B;PDE4C;PDE4B;PDE3B;PDE7A
prerank,NAD binding (GO:0051287),-0.4093668375692919,-1.2811348063832044,0.15625,0.6166582737692736,1.0,10/26,22.07%,ALDH1A1;CRYL1;BDH2;QDPR;ZC3HAV1;ME1;HADH;CRYZ;SORD;ALDH2
prerank,protein phosphatase binding (GO:0019903),0.39991174896157,1.2801938667736814,0.1186046511627907,1.0,1.0,31/117,16.35%,PXN;SMTNL1;CEACAM1;EGFR;PDLIM4;SH3RF2;CDH5;SMTNL2;EIF2AK3;ATP2B4;AKAP11;MAP3K5;PIK3R2;BOD1L1;ANAPC5;MTMR3;ANAPC7;MASTL;PTPRT;ANK1;STRN;ENSA;MVP;PTPA;SMG7;ANAPC4;BAD;ADCY8;ERBB2;TBK1;AP3B1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.37253321356404073,-1.2740327271599827,0.11818181818181818,0.6263452631846166,1.0,7/37,8.23%,SLC22A8;SLCO3A1;SLCO1C1;SLC22A6;SLC22A4;COX6B1;SLCO2A1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.4939052301929089,1.2724164409951018,0.20176730486008837,1.0,1.0,9/27,12.99%,ITPR2;SLC12A2;SLC12A3;ATP2B4;CNNM2;MRS2;ZDHHC13;TUSC3;AQP1
prerank,channel activity (GO:0015267),0.4552470595970293,1.2702789257904605,0.1772853185595568,1.0,1.0,9/41,19.72%,CHRNB3;TRPV4;MPV17;PANX2;AQP1;TRPV2;TMEM266;CHRNA7;BAX
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5910152716514125,1.268571780991368,0.2013888888888889,1.0,1.0,3/11,12.99%,CNGB1;CNGA4;AQP1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5215744340326877,1.2675650669687442,0.2064,1.0,1.0,1/19,0.26%,EFNA5
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.39807022170106654,-1.2570919910003753,0.1550632911392405,0.6648892350142136,1.0,11/27,22.66%,MED21;POLR3B;TENT2;POLR3A;POLR3H;POLR2F;POLR2A;POLR2J;POLR2D;POLR1C;POLR1F
prerank,serine-type peptidase activity (GO:0008236),0.4006931443196765,1.2568368083343788,0.15936739659367397,1.0,1.0,22/96,20.97%,CORIN;CTRC;FAP;KLK2;NAALAD2;PCSK5;CD5L;DPP4;PCSK7;PROC;CELA1;HTRA2;PLG;TYSND1;MBTPS1;MASP2;TMPRSS7;RHBDF1;GZMK;HGF;PLAT;PRSS8
prerank,endopeptidase activator activity (GO:0061133),0.6034172887722605,1.2566098694265058,0.21880650994575046,1.0,1.0,3/10,6.99%,APH1B;PSME3;NLRC4
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.42152648232494827,1.2558776917934684,0.17857142857142858,1.0,1.0,6/60,1.81%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK
prerank,zinc ion binding (GO:0008270),-0.26127494064161616,-1.254442773077949,0.025,0.6619266611621586,1.0,52/293,10.98%,SMAD3;MYRIP;ECE1;SHANK3;ENPP1;MSRB3;KDM5C;ARHGEF2;CLIP1;PAPPA;ENPP2;PHF8;KDM2B;CHD4;SAMHD1;PDXK;UBA5;MT1G;MT1A;MT1F;MT1H;MT1B;MT1E;MT1M;MT1X;LITAF;NAPEPLD;RPS29;ENPP3;CXXC5;ACE;RPS27;GRIN2B;BLM;KLF4;RNF125;RBSN;UPB1;ARIH1;RPH3A;ZFP37;MNAT1;GCH1;ZCCHC4;RNF11;PRDM2;PDE2A;USP33;TRIM28;TES;SEC23A;BMI1
prerank,vinculin binding (GO:0017166),0.5770442940678217,1.2524039491443493,0.24468085106382978,1.0,1.0,3/11,7.06%,UTRN;PXN;DAG1
prerank,transaminase activity (GO:0008483),0.5795760234770674,1.2506793528278384,0.21516754850088182,1.0,1.0,4/11,13.15%,AADAT;ABAT;BCAT2;GOT1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5589834423632286,1.249563231049995,0.2231543624161074,1.0,1.0,2/13,1.67%,ALDH1A3;ALDH9A1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4145270093386486,1.2480672910639559,0.1606022584692597,1.0,1.0,22/71,15.20%,UBASH3B;PTPN13;PTPRF;EYA1;PTPDC1;PTPN14;TPTE;PTPN22;PTPRC;PTP4A2;PTPRJ;MTMR6;MTMR3;PTPRT;HACD2;PTPN18;PTEN;PTPRA;PALD1;PTPRU;PTPRO;PTPN6
prerank,BMP binding (GO:0036122),-0.5178830294756711,-1.2469806202248215,0.2013888888888889,0.6741987868882099,1.0,3/11,6.66%,ENG;BMPR2;GREM2
prerank,chemokine activity (GO:0008009),-0.3730075747885433,-1.2457773329520616,0.1414790996784566,0.6681363458499575,1.0,24/31,52.22%,CXCL16;CXCL12;CCL13;CCL19;CCL2;CXCL10;CCL25;CCL28;CCL5;CXCL5;CCL11;CCL15;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,voltage-gated chloride channel activity (GO:0005247),0.5898559976362105,1.2372786144639272,0.23128119800332778,1.0,1.0,3/10,6.18%,ANO6;CLCN2;CLCN1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4442719842066004,-1.2364963273454408,0.19452054794520549,0.6752277444992721,1.0,4/16,3.27%,PTPRB;PTPRM;PTPRG;PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4442719842066004,-1.2364963273454408,0.19452054794520549,0.6752277444992721,1.0,4/16,3.27%,PTPRB;PTPRM;PTPRG;PTPRK
prerank,double-stranded DNA binding (GO:0003690),0.3484866479057352,1.2349902514347038,0.043434343434343436,1.0,1.0,66/531,11.92%,MEOX2;KLF5;ETV4;NFATC2;ETV1;PAX9;FOXD2;NR3C2;DLX1;POU4F3;RARB;NFATC1;ZBTB32;KLF12;PBX1;EGFR;BHLHE22;ZBTB20;ETV5;RUNX2;TDG;MSH6;HOXB6;GLI2;TEF;KLF3;FOXK1;FOXO3;SOX9;NPAS2;GLIS2;SATB1;KLF10;NTHL1;CREB3L1;ZFP1;SP3;BHLHE40;ONECUT1;HIC1;PAX3;HOXC10;TBX2;ONECUT3;MSH2;RARA;MAFG;USF2;LHX6;ISL1;PKNOX2;LIN28B;TBX18;MECP2;HMGB1;RORB;POU4F1;DBP;TLX3;TFEB;RARG;EN2;EGR1;TDP1;TOP1;MEN1
prerank,diacylglycerol kinase activity (GO:0004143),0.5745146998517264,1.2348000977063422,0.25220458553791886,1.0,1.0,2/11,3.58%,DGKA;DGKZ
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5697156645441631,1.2304517721113808,0.2552083333333333,1.0,1.0,7/10,29.80%,TNFAIP3;STAMBPL1;STAMBP;CYLD;OTUD4;DESI2;OTUD5
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.47980571910749403,-1.229884322012566,0.2146341463414634,0.6850707980765669,1.0,4/12,13.15%,PIK3R3;PIK3R6;PIK3C2A;IPMK
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5181844559014469,-1.229685357231542,0.24,0.6759479190266003,1.0,6/10,37.88%,TATDN1;DCLRE1B;DCLRE1C;EXO1;MGME1;FEN1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5198600227168403,-1.2290358069255545,0.24819277108433735,0.6685582732984084,1.0,3/10,7.01%,MECOM;SETD5;PRDM16
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3282572961749637,-1.2287248971162892,0.11320754716981132,0.660332848081103,1.0,13/51,13.12%,SLC22A8;SLCO3A1;SLC7A5;SLCO1C1;SLC22A6;SLC22A4;SLC5A6;SLCO2A1;SLC25A30;SLC25A11;SLC16A2;TMEM241;MFSD2A
prerank,sialyltransferase activity (GO:0008373),-0.4287360318878041,-1.2285909305962763,0.19791666666666666,0.6517953636570151,1.0,6/20,5.46%,ST3GAL6;ST3GAL5;ST3GAL1;ST8SIA4;ST6GALNAC3;ST6GALNAC2
prerank,phosphate ion binding (GO:0042301),-0.5135558951732881,-1.2283772898380676,0.2222222222222222,0.6437052301049946,1.0,2/10,9.40%,RPH3A;PDE2A
prerank,store-operated calcium channel activity (GO:0015279),-0.514270818770239,-1.2283085263259736,0.23820224719101124,0.6353944067370567,1.0,5/10,18.97%,TRPC3;TRPC1;ORAI1;TRPC7;STIM2
prerank,Tat protein binding (GO:0030957),0.5764019031251668,1.2272916454090417,0.26666666666666666,1.0,1.0,1/10,0.33%,MDFIC
prerank,transcription coregulator binding (GO:0001221),0.4236665530728835,1.2264003359607194,0.2051983584131327,1.0,1.0,8/50,11.64%,RORA;VGLL4;UBE2I;PGR;CTCF;CHD6;HDAC6;ZBTB49
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.49944910807721665,1.2263778536123402,0.24175824175824176,1.0,1.0,6/20,11.28%,MOGAT2;MOGAT3;GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.48128478902402794,1.2235890671488758,0.2119309262166405,1.0,1.0,6/25,11.64%,POR;FMO4;FMO2;FMO1;MICAL3;MSMO1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.4812757591149851,-1.2221959534254272,0.23515439429928742,0.644546118164192,1.0,3/12,13.66%,POU2F1;HDAC1;TBPL1
prerank,cadherin binding (GO:0045296),0.35085588816050206,1.2196490232218116,0.10041407867494824,1.0,1.0,92/315,20.20%,STXBP6;AHNAK;ITGA6;DOCK9;FMNL2;CDH13;F11R;PARVA;ARHGAP18;CDH11;PLCB3;EGFR;CDH5;CAPZB;CDH17;STK38;PFKP;CDH9;GIGYF2;TJP2;ADD1;EXOC3;SRC;ATIC;LRRC59;USP8;ZC3H15;PACSIN2;RDX;CKAP5;BAG3;CDH2;PTPRJ;PKP4;CHMP5;STK24;CALD1;SFN;FLNB;PTPRT;CGN;IST1;DIAPH3;TBC1D2;SH3GLB2;COBLL1;CHMP4B;APC;SNX2;NOP56;EMD;CTTN;CEMIP2;AHSA1;DDX6;KIF5B;RTN4;BZW1;PTPRO;CTNNA1;GLOD4;RAN;CDH1;SNX5;EZR;SNX1;YWHAE;TNKS1BP1;PPP1CA;MB21D2;SCRIB;UBFD1;SPTBN1;STX5;EHD1;KLC2;CDH15;CDH3;PSMB6;PRDX6;CDH22;MRE11;GCN1;BAIAP2;TBC1D10A;UNC45A;MRTFB;ARGLU1;LYPLA2;ACVR1;EIF4G2;GOLGA3
prerank,cell adhesion mediator activity (GO:0098631),0.49184120496841505,1.2163200557750193,0.228486646884273,1.0,1.0,2/24,4.59%,NTNG1;DSCAM
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5685105084661182,1.2153924245325474,0.25765765765765763,1.0,1.0,3/11,7.80%,EGFR;MAP3K1;MAP3K5
prerank,ATPase activator activity (GO:0001671),-0.41366833836841377,-1.214022233439817,0.2103960396039604,0.6578850274341028,1.0,5/20,10.37%,DNAJC1;DNAJB2;DNAJA1;ATP1B1;ATP1B2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3958073447635181,-1.2138526999295811,0.21203438395415472,0.6499605874667088,1.0,7/24,13.57%,DAPK1;MKNK2;CAMK2A;MKNK1;CAMK4;MAPKAPK2;MAPKAPK3
prerank,ribosome binding (GO:0043022),-0.3443697061534602,-1.2138028515477877,0.15019762845849802,0.6419733830113489,1.0,22/46,25.11%,CPEB4;EIF3C;NOMO1;NAA15;CPEB2;SEC61B;ZC3H12A;EIF2A;YTHDF1;SERBP1;NCLN;CPEB1;MRPS27;RACK1;MAIP1;SHFL;TMCO1;C1QBP;EEF2;OXA1L;YTHDF3;GEMIN5
prerank,transition metal ion binding (GO:0046914),-0.243833078756606,-1.2118253056699309,0.05,0.6391466386164664,1.0,78/397,13.44%,MOXD1;SMAD3;MYRIP;ECE1;SHANK3;ENPP1;MSRB3;KDM5C;ARHGEF2;CLIP1;NOS3;PAPPA;MPPED2;ENPP2;PHF8;KDM2B;FTH1;ATP7A;CHD4;SAMHD1;WRN;PDXK;UBA5;MT1G;MT1A;MT1F;MT1H;MT1B;MT1E;MT1M;MT1X;COMMD1;LITAF;HMGCL;NAPEPLD;LACC1;RPS29;ENPP3;CXXC5;ACE;FTL;SOD3;RPS27;AOX1;GRIN2B;BLM;KLF4;SLC11A2;RNF125;RBSN;UPB1;ARIH1;RPH3A;ZFP37;MNAT1;GCH1;ADCY2;ZCCHC4;RNF11;PRDM2;PDE2A;USP33;TRIM28;TES;SEC23A;B4GALT1;BMI1;B4GALT7;ETHE1;DPP3;LOXL3;NUDT12;NFU1;ABCE1;KDM7A;CALB1;ME1;ADH1A
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4276304632157593,1.208903125251736,0.21655172413793103,1.0,1.0,12/46,14.78%,MGAT3;OGT;B3GALT1;GCNT4;B4GAT1;B3GLCT;EXTL2;GCNT2;PIGA;HEXA;HEXB;EXT1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.36916209504722697,-1.2085720369414776,0.20569620253164558,0.6402333200700976,1.0,14/32,24.62%,SLC6A6;SLC6A9;SLC7A5;SLC25A38;SLC43A2;SLC38A7;SLC1A1;SLC3A2;SLC38A5;SLC1A4;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,C-C chemokine receptor activity (GO:0016493),0.4840531102667859,1.205931556764752,0.2375,1.0,1.0,1/21,0.78%,ACKR3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.501902128262734,1.1938967013599888,0.2528180354267311,1.0,1.0,5/16,13.33%,TDG;NTHL1;SARM1;OARD1;ADPRS
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4192930892345047,-1.190065180112044,0.22727272727272727,0.6826501079869017,1.0,4/16,7.16%,WRN;BLM;NAV2;MCM6
prerank,G protein-coupled amine receptor activity (GO:0008227),0.47976897893533454,1.18852959008702,0.2551505546751189,1.0,1.0,1/22,0.35%,HRH1
prerank,serotonin receptor activity (GO:0099589),0.47976897893533454,1.18852959008702,0.2551505546751189,1.0,1.0,1/22,0.35%,HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.47976897893533454,1.18852959008702,0.2551505546751189,1.0,1.0,1/22,0.35%,HRH1
prerank,ion gated channel activity (GO:0022839),-0.38987781231941276,-1.1852247535328235,0.21100917431192662,0.6881228451292467,1.0,9/24,17.69%,ANO1;ANO4;ANO3;KCNT1;TTYH2;TMEM63B;TTYH3;ANO5;TTYH1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3316957466679005,1.184668068787363,0.07142857142857142,1.0,1.0,65/597,10.25%,MEOX2;BNC2;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;FOXD2;NR3C2;DLX1;POU4F3;RARB;NFATC1;ZBTB32;KLF12;PBX1;BHLHE22;ZBTB20;ETV5;RUNX2;HOXB6;GLI2;TEF;CHD3;KLF3;SPI1;FOXK1;BEND3;FOXO3;SOX9;NPAS2;GLIS2;HDAC4;KLF10;CREB3L1;ZFP1;SP3;BHLHE40;ONECUT1;ORC5;CTCF;HIC1;NCOR1;PAX3;HOXC10;TBX2;ONECUT3;RARA;SUV39H1;MAFG;USF2;LHX6;ISL1;PKNOX2;FOXK2;LIN28B;TBX18;FOXJ1;HMGB1;RORB;POU4F1;DBP;ORC3;TLX3
prerank,exopeptidase activity (GO:0008238),0.4148569538342377,1.1818500623128259,0.23848238482384823,1.0,1.0,13/50,12.55%,XPNPEP2;FAP;NAALAD2;CPE;CPA2;RNPEP;DPP4;BLMH;LNPEP;MME;XPNPEP3;KDM8;LTA4H
prerank,hydro-lyase activity (GO:0016836),0.4214318242229061,1.1787648595644915,0.2579750346740638,1.0,1.0,12/41,17.95%,EHHADH;CYP2S1;HADHB;HACD4;HSD17B4;HACD2;NAXD;ENO3;GMDS;PCBD2;ENO2;CDYL
prerank,glutamate receptor binding (GO:0035254),-0.4283146716750336,-1.1776891749179539,0.24594594594594596,0.7006259460976645,1.0,6/17,8.50%,HIP1;SHANK3;GNAS;SQSTM1;IGSF11;CAMK2A
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4984852562707009,1.1768103614268692,0.2757009345794392,1.0,1.0,11/18,20.75%,SOCS5;WDR81;SOCS6;PIK3R2;SOCS4;SOCS7;CCKBR;SOCS1;WDR91;SOCS2;CISH
prerank,AMP binding (GO:0016208),-0.49741903752502153,-1.1748074180730443,0.25116279069767444,0.700666216602701,1.0,2/11,2.26%,PRKAG2;MPPED2
prerank,anion transmembrane transporter activity (GO:0008509),-0.47376934377998325,-1.171692905560763,0.2740740740740741,0.700869693536924,1.0,3/12,3.59%,ABCG2;SLC39A8;SLC22A6
prerank,GTPase activator activity (GO:0005096),0.33783780926552476,1.1689333748929087,0.16303219106957426,1.0,1.0,39/313,6.44%,ARHGAP42;SIPA1L1;DOCK9;DLC1;ARHGEF28;RGS6;DOCK5;RGS14;ARHGAP31;PLCE1;ARHGAP18;ARHGAP32;GRTP1;RAPGEF3;PSD;RAP1A;ARHGAP9;RGL1;ARAP1;RAB3IL1;DOCK1;DENND2D;SGSM2;DENND2C;NF1;AKAP13;EIF2B3;OPHN1;RACGAP1;VAV2;GNAQ;WDR41;NUCB1;HPS1;DOCK2;RAPGEF4;ARHGEF5;ARHGAP26;RAB3GAP2
prerank,C-C chemokine binding (GO:0019957),0.4660460917459905,1.1679759616602428,0.2863849765258216,1.0,1.0,1/22,0.78%,ACKR3
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.44179955658286457,-1.166792067980805,0.2715736040609137,0.7074968175686984,1.0,5/13,16.26%,PIP5K1B;PIK3C2A;PIP4K2A;PIP4K2C;PIP5K1A
prerank,pre-mRNA binding (GO:0036002),0.4515581429873392,1.1664119909896504,0.3073394495412844,1.0,1.0,8/28,17.58%,RNPC3;CELF1;ZRSR2;RBM22;CELF2;CELF4;TRA2B;SLU7
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.33677947365239586,1.16563884630202,0.17784877529286475,1.0,1.0,30/254,10.15%,MEOX2;KLF5;ETV4;ETV1;FOXD2;POU4F3;NFATC1;ETV5;NFIA;FOXO3;SOX9;PGR;GLIS2;ZNF585B;ZNF585A;REL;KLF10;CREB3L1;ONECUT1;NRF1;HOXC10;ZFP62;RREB1;E4F1;FOXK2;PLSCR1;FOXJ1;SMARCD2;POU4F1;DBP
prerank,myosin binding (GO:0017022),-0.3058028749885506,-1.1656216436559055,0.18359375,0.702731607941841,1.0,12/55,18.80%,MYRIP;DMD;RAB6B;RAB3C;LARP6;TRIOBP;RAB11A;NKD2;LLGL2;RAB3B;RAB11B;MLPH
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3863453680488191,1.1629424207579255,0.25892857142857145,1.0,1.0,11/75,10.76%,RDH10;EHHADH;RDH5;MDH1B;HADHB;DHRS4;HSD17B4;ADH5;MDH1;AKR1B10;KCNAB1
prerank,phospholipase C activity (GO:0004629),0.45509230599239,1.1611042730630252,0.30390738060781475,1.0,1.0,4/25,3.86%,PLCD3;PLCE1;PLCB3;PLCL1
prerank,protein kinase inhibitor activity (GO:0004860),0.4181393891930025,1.158688946509698,0.2729766803840878,1.0,1.0,18/42,22.32%,PARVA;SPRED1;SPRY4;IBTK;GMFB;MAPK8IP1;HEXIM1;SPRED2;CDKN1C;CIT;SOCS1;INKA2;RPTOR;CEP43;NCK1;GSKIP;YWHAB;TAOK3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4995853041503971,1.157633620271545,0.29790660225442833,1.0,1.0,5/15,13.00%,SLC25A12;SLC1A7;SLC1A6;SLC25A13;SLC25A22
prerank,cytokine receptor binding (GO:0005126),-0.28490620908284814,-1.1541225097670744,0.16853932584269662,0.7269364100896754,1.0,14/83,9.58%,SMAD3;OSMR;IL13RA1;TGFBR3;IL6R;FKBP1A;IL1RAP;IL18;LIFR;CXCL12;TRAF6;JAK2;VEGFC;IL34
prerank,dynactin binding (GO:0034452),0.5180175806784949,1.1539419610952126,0.29069767441860467,1.0,1.0,5/12,15.49%,PAFAH1B1;GSK3B;HOOK3;HTT;SNX5
prerank,intracellular chloride channel activity (GO:0061778),-0.4194295808586014,-1.1520430153793904,0.29362880886426596,0.7168882265662893,1.0,8/16,21.29%,ANO1;ANO4;ANO3;TTYH2;TTYH3;ANO5;TTYH1;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4194295808586014,-1.1520430153793904,0.29362880886426596,0.7168882265662893,1.0,8/16,21.29%,ANO1;ANO4;ANO3;TTYH2;TTYH3;ANO5;TTYH1;ANO2
prerank,regulatory RNA binding (GO:0061980),0.4202932858841673,1.1491017966202823,0.2881844380403458,1.0,1.0,17/38,25.78%,DND1;PIWIL2;RBM10;ZNF346;TLR7;AGO1;PUM2;DICER1;SPOUT1;DHX9;PUM1;ELAVL1;ZC3H7B;DDX21;FMR1;PNPT1;AGO2
prerank,monocarboxylic acid binding (GO:0033293),0.46904496301957993,1.1467598894180766,0.2961730449251248,1.0,1.0,2/18,7.46%,NR2F2;RARA
prerank,fatty acid synthase activity (GO:0004312),0.5426737923616503,1.146508748660486,0.31386861313868614,1.0,1.0,4/10,13.29%,ELOVL5;ELOVL1;ELOVL2;ELOVL6
prerank,mRNA methyltransferase activity (GO:0008174),-0.4685404103976079,-1.1440159266641137,0.3198090692124105,0.7324828562137701,1.0,8/12,36.62%,NSUN2;TRMT61B;METTL16;METTL8;CMTR2;METTL14;TRMT61A;TRMT10C
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3497865171649075,1.142713373673464,0.24914675767918087,1.0,1.0,25/147,8.67%,DOCK9;ARHGEF28;DOCK5;PLCE1;RAPGEF3;PSD;RAP1A;RGL1;RAB3IL1;DOCK1;DENND2D;DENND2C;AKAP13;EIF2B3;VAV2;WDR41;NUCB1;HPS1;DOCK2;RAPGEF4;ARHGEF5;RAB3GAP2;FRMD7;KALRN;RAPGEF6
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.30708186413430527,-1.1406362677152129,0.2345679012345679,0.734260788828579,1.0,22/53,24.62%,SLC7A11;SLC47A1;SLC6A9;SLC7A5;SLC7A1;SLC7A6;SLC15A4;SLC25A38;CTNS;SLC43A2;SLC1A3;SLC38A7;SLC1A1;SLC3A2;SLC22A2;SLC38A5;SLC25A18;SLC1A4;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,sodium channel regulator activity (GO:0017080),0.4116477299306758,1.140546448552211,0.2943661971830986,1.0,1.0,8/37,11.96%,NEDD4L;CAMK2D;GPLD1;ATP2B4;FXYD6;SCN2B;NEDD4;SGK1
prerank,glutathione transferase activity (GO:0004364),0.4492719352540782,1.1396050402455187,0.3067484662576687,1.0,1.0,6/23,12.22%,MGST2;GSTZ1;GSTA4;GSTA3;GSTK1;LANCL1
prerank,hormone activity (GO:0005179),0.3964792209251189,1.1394219157459944,0.28552971576227393,1.0,1.0,5/54,5.62%,INHBB;INSL6;GNRH1;PTHLH;APLN
prerank,cation:chloride symporter activity (GO:0015377),0.5367719129784014,1.1374246153522474,0.3304042179261863,1.0,1.0,3/10,4.35%,SLC12A2;SLC12A4;SLC12A3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.44954016423599635,1.1361136650496417,0.3102918586789555,1.0,1.0,1/28,0.24%,EDA
prerank,adenyl nucleotide binding (GO:0030554),0.5347251448985875,1.1358989475709258,0.34385964912280703,1.0,1.0,5/11,19.36%,HSPH1;SIL1;BAG3;BAG2;GRPEL2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5347251448985875,1.1358989475709258,0.34385964912280703,1.0,1.0,5/11,19.36%,HSPH1;SIL1;BAG3;BAG2;GRPEL2
prerank,adenyl ribonucleotide binding (GO:0032559),-0.23926362197951845,-1.1338321715271906,0.027777777777777776,0.7459217862625888,1.0,69/291,16.55%,PRKAG2;DAPK1;KSR1;RAPGEF2;INSR;MYO1B;ENPP1;MAP3K20;MARK1;LATS2;MPPED2;MTHFS;MYO6;SNRK;TGFBR1;AKT3;ATP7A;PDXK;ACVRL1;RPS6KA5;STK17B;RHOBTB3;SIK1;BLM;SMC4;TRNT1;HSPA8;TWF1;HARS1;ABCC6;MCM6;ABCD4;PDE10A;CDK6;UBA2;TAP2;SYN1;MKNK2;AKT1;MYH10;PDE2A;CDKL5;VPS4A;TRIB1;MKNK1;OXSR1;ACLY;ABCD2;PMVK;ABCE1;ABCA2;PDE4A;PXK;SMARCA5;ME1;SPHK1;MYO18A;SYN3;MTHFD1L;ABCG1;MVK;MTPAP;P2RX7;HACL1;PEX6;P2RX4;EIF4G1;NOL9;PEX1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.44787303069406925,-1.133576669584746,0.2889447236180904,0.7388497240028881,1.0,6/12,27.94%,CTSH;NOD1;RACK1;RPS27L;PYCARD;CASP1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.45489821048989326,-1.1308252946792872,0.3103448275862069,0.738615931628348,1.0,6/11,29.19%,LEF1;GATA2;ZXDC;EHMT2;THAP7;TAF9
prerank,SUMO transferase activity (GO:0019789),0.48124371243510067,1.1291951973820222,0.3081967213114754,1.0,1.0,4/16,11.54%,UBE2I;HDAC4;PIAS2;RANBP2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.48561309307233363,1.1286349469253723,0.3232830820770519,1.0,1.0,8/14,25.74%,POP4;POP7;TSEN34;RPP14;RPP21;RPP30;PRORP;TSEN2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.42292791798758855,1.1255776673606372,0.32,1.0,1.0,9/31,15.27%,SLC12A2;SLC12A4;SLC12A3;KCNK1;KCNK5;AQP1;KCNK10;KCNK4;SLC12A8
prerank,chemoattractant activity (GO:0042056),0.4358965298745485,1.1246004988679987,0.312406576980568,1.0,1.0,1/26,0.26%,FGF7
prerank,RNA polymerase binding (GO:0070063),-0.39271803377875947,-1.1234552632083619,0.296195652173913,0.7519602817379044,1.0,11/18,25.26%,YTHDC2;CCNT2;CCNT1;PHRF1;STOM;PPIB;ZFP36;SCAF8;ANP32B;BRCA1;TCERG1L
prerank,inward rectifier potassium channel activity (GO:0005242),0.4474885222709021,1.1213279819121655,0.32965299684542587,1.0,1.0,4/24,5.58%,KCNJ4;KCNJ16;KCNK1;KCNJ13
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.45133888299910074,1.12097185352874,0.3403298350824588,1.0,1.0,3/23,1.51%,PLCD3;PLCE1;PLCB3
prerank,frizzled binding (GO:0005109),0.40873259163259285,1.117990632628785,0.3140376266280753,1.0,1.0,8/34,14.10%,WNT10A;WNT2B;WNT16;WNT5A;ZNRF3;DVL3;WNT9A;FZD7
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5079243847361562,1.1175697458791523,0.3344887348353553,1.0,1.0,2/12,4.76%,B3GALT1;B4GAT1
prerank,glycine binding (GO:0016594),-0.4481431388890939,-1.1173890998726943,0.33260393873085337,0.7613292579395242,1.0,4/11,11.74%,GRIN3A;GRIN2B;GRIN1;GLRA2
prerank,metalloendopeptidase activity (GO:0004222),0.36572876255024656,1.1170220675717009,0.2900378310214376,1.0,1.0,19/76,16.92%,ADAMTS14;MMP28;ADAMTS12;ADAMTSL5;ADAMTS1;ADAM19;MMP15;ADAMTS19;ADAM10;ADAMTS2;MMP12;MME;MMP16;ADAMTSL4;MIPEP;NLN;ZMPSTE24;ADAMTS20;MMP14
prerank,leak channel activity (GO:0022840),0.4622680021449551,1.1157743964240732,0.32689210950080516,1.0,1.0,5/18,13.89%,NALCN;KCNK1;KCNK5;KCNK10;KCNK4
prerank,ATP binding (GO:0005524),-0.23596599084730419,-1.1151912182737145,0.09090909090909091,0.7599440243586306,1.0,62/266,16.55%,PRKAG2;DAPK1;KSR1;INSR;MYO1B;ENPP1;MAP3K20;MARK1;LATS2;MTHFS;SNRK;TGFBR1;AKT3;ATP7A;PDXK;ACVRL1;RPS6KA5;STK17B;RHOBTB3;SIK1;BLM;SMC4;TRNT1;HSPA8;TWF1;HARS1;ABCC6;MCM6;ABCD4;CDK6;UBA2;TAP2;SYN1;MKNK2;AKT1;MYH10;CDKL5;VPS4A;TRIB1;MKNK1;OXSR1;ACLY;ABCD2;PMVK;ABCE1;ABCA2;PXK;SMARCA5;SPHK1;MYO18A;SYN3;MTHFD1L;ABCG1;MVK;MTPAP;P2RX7;HACL1;PEX6;P2RX4;EIF4G1;NOL9;PEX1
prerank,GDP binding (GO:0019003),0.3653021055510056,1.1149362615687257,0.2950191570881226,1.0,1.0,21/63,23.21%,RAP1A;RAB8B;RAB29;MRAS;RASEF;NRAS;KRAS;ARF6;MIEF1;ARL8B;RAN;GEM;RAB21;RAB27B;RAB5A;RALA;RAB18;RHEBL1;GNAI3;ARL3;RAB9A
prerank,calcium channel inhibitor activity (GO:0019855),-0.44630823474760983,-1.1094567943663254,0.35365853658536583,0.7692224369427922,1.0,3/11,6.63%,ITPR1;FKBP1A;CALM1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.4667139652679988,1.10764124894393,0.3466453674121406,1.0,1.0,4/18,9.05%,ALDH1A3;ALDH9A1;ALDH18A1;AKR1B10
prerank,cation channel activity (GO:0005261),0.3499590851326745,1.1074408551686323,0.3028503562945368,1.0,1.0,18/94,14.45%,PIEZO2;OTOP1;NALCN;TRPM3;ANO6;SLC24A1;TRPV4;KCNK1;SLC4A11;PIEZO1;KCNK5;ANO10;AQP1;PKD1;TRPV2;KCNK10;KCNK4;TMEM63A
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3257308113183323,-1.106175566010274,0.2984126984126984,0.7711684008398328,1.0,9/34,14.92%,FAM20A;IGF2;CCNT2;CALM1;MAP2K2;CCNT1;RICTOR;CALM3;CDK5R1
prerank,peptidoglycan binding (GO:0042834),-0.4643095963331519,-1.1022734711081357,0.37644341801385683,0.7753267467476118,1.0,6/10,39.97%,NOD1;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,actin monomer binding (GO:0003785),0.442926969605209,1.1018705136224816,0.35275080906148865,1.0,1.0,4/22,10.66%,PRKCE;COBL;ABL2;MTSS1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3284433127448883,-1.1012689689530932,0.26174496644295303,0.7704804367465452,1.0,7/35,4.50%,PLCB4;GPCPD1;ENPP1;MPPED2;ENPP2;NAPEPLD;ENPP3
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.2638376039773499,-1.10044260113086,0.24203821656050956,0.7657473597569996,1.0,25/100,12.04%,HIP1;PARD3;OSBPL8;ADAP2;MYO1B;CYTH3;COMMD1;SNX21;ZFYVE28;MYO10;ARAP3;DAPP1;KCNH1;HIP1R;SNX24;RPH3A;WIPI1;AKT1;FCHSD2;OSBPL5;IQGAP2;RUBCN;TECPR1;PLEKHF1;DENND1A
prerank,DNA-binding transcription factor binding (GO:0140297),-0.23468027130079266,-1.0907185602428766,0.12857142857142856,0.7859528182096499,1.0,44/189,16.94%,SMAD3;RUNX1T1;RBPJ;MEF2D;PPARD;TBX3;LMO2;CHD4;PRDM5;EP300;CRTC3;CXXC5;RBL1;SIK1;NPM1;KLF4;HIRA;HDAC7;HDAC9;HDAC1;MEF2A;PRDM16;PTMA;CREB1;MAP3K10;PIAS3;AR;NFYB;ATF2;CRTC2;KDM1A;SP1;BBS2;NOC2L;TAL1;YWHAZ;ID2;MKKS;TLE5;RBL2;MYOCD;HHEX;MTDH;DDX20
prerank,manganese ion binding (GO:0030145),0.38748613687380973,1.0906346742403679,0.340080971659919,1.0,1.0,5/48,6.49%,FAM20C;ARG1;XYLT2;PPM1M;ABL2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.48487286058568035,1.0871266271499243,0.3583916083916084,1.0,1.0,2/13,5.95%,RGS14;GDI1
prerank,PDZ domain binding (GO:0030165),0.3709339280255544,1.0861997798069967,0.3324607329842932,1.0,1.0,4/61,1.66%,CXADR;F11R;KCNJ4;FZD2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4487305724796952,-1.0841093666534545,0.3673469387755102,0.797116407349161,1.0,3/10,12.83%,PHF8;KDM2B;KDM7A
prerank,mRNA 5'-UTR binding (GO:0048027),-0.36339939497692164,-1.0821284498544756,0.36827195467422097,0.7952379859769612,1.0,11/24,24.74%,LARP6;RPS7;RPL26;RPL41;MYH10;NCL;DHX36;MRPS11;GNL3;RPL5;RPS14
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4483283897309045,1.0821220689292304,0.3553054662379421,1.0,1.0,6/17,9.88%,ATP8B1;PITPNC1;PCTP;ATP8B2;ABCA1;ATP10B
prerank,gamma-tubulin binding (GO:0043015),0.4398991770126728,1.082057198396305,0.3796875,1.0,1.0,9/21,22.07%,RACGAP1;BRSK1;TUBGCP5;RAB11FIP5;B9D2;ARHGEF7;OFD1;TUBGCP6;BLOC1S2
prerank,calcium channel regulator activity (GO:0005246),-0.32728296801141726,-1.0820045570419365,0.3296296296296296,0.7882646974755335,1.0,9/37,15.44%,ITPR1;PRKG1;FKBP1A;CALM1;CACNG7;NRXN1;REM1;NRXN2;SRI
prerank,nucleotide diphosphatase activity (GO:0004551),-0.4123625290956803,-1.0813802632958198,0.37531486146095716,0.7829160457247575,1.0,7/14,21.53%,ENPP1;NUDT13;NUDT3;ENPP4;NUDT12;NUDT11;CILP
prerank,myosin V binding (GO:0031489),-0.4005674659204965,-1.0804587089506568,0.3301204819277108,0.7782871954067785,1.0,6/15,22.08%,RAB6B;RAB3C;RAB11A;RAB3B;RAB11B;RAB10
prerank,protein phosphatase activator activity (GO:0072542),-0.40911845156931886,-1.0798380799676355,0.33653846153846156,0.7728779564057838,1.0,8/13,32.61%,IGFBP3;CALM1;CALM3;PPP2R5A;PPP2R5E;PPP2R5D;PPP1R15A;B3GAT3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.49886268791619687,1.0795721486847063,0.3697068403908795,1.0,1.0,1/11,0.64%,SGMS2
prerank,calcium channel activity (GO:0005262),-0.2689834565991873,-1.0793067432114025,0.3047619047619048,0.7673311627455943,1.0,26/84,26.28%,CACNA2D3;SLC24A3;TRPC3;TRPC1;ANXA2;CACNB2;ORAI1;GRIN1;CACNG7;TRPC7;TRPM7;P2RX4;ANXA6;CACHD1;TRPM2;OPRM1;STIM2;CACNA2D4;TPCN2;TMCO1;CACNG4;PKD2L2;ANXA9;PKD2L1;PKD1L3;CACNA1B
prerank,death domain binding (GO:0070513),0.4995254546106491,1.0789630164703221,0.3844797178130511,1.0,1.0,3/11,8.84%,TRADD;MCL1;IRGM
prerank,protein homodimerization activity (GO:0042803),0.3026829319507828,1.0775728390859913,0.2901606425702811,1.0,1.0,127/589,17.74%,TENM2;ALDH1A3;F11R;INHBB;STC2;FGFR1;NR2F2;FOXP2;CEACAM1;CAMK2D;FAP;SLC8B1;AXIN1;PDLIM4;SLC39A13;GLCE;RDH5;TDG;MSH6;FXR2;KIF20B;NAGA;KMT2A;CAV2;TPD52;AADAT;ADD1;PHETA2;PAXX;S100A6;IRAK3;PIP4K2B;ATIC;TSG101;BHLHE40;CEP131;ADAM10;CLCN1;TMEM192;RABEP1;TRIM21;HOGA1;NRF1;TARS2;MCL1;NLRC4;MSH2;USF2;MAP3K5;DPP4;HSD17B4;S100B;DEFA6;COQ9;INPP5F;RPE;PDCD6IP;CASQ2;TBX18;PLEK;CUBN;ST6GAL1;PTPRT;CANT1;KARS1;ADRA2A;GSTZ1;GSTA4;TPR;RCHY1;KLHL7;CHMP4A;CHMP4B;MME;PAFAH1B2;GLDC;MZF1;XPNPEP3;EFEMP2;PRPS1;PRPS1L1;SNX2;CHMP4C;DGCR8;PGRMC1;CRPPA;MAP3K21;ABCD1;GEN1;PTPA;MYOM3;ABCB7;ATG7;STARD3;ERN1;SFPQ;AIMP1;FXR1;TXN;PTPRO;ERBB4;ABCB9;EXT1;FZD9;NECTIN3;TMEM266;ADCY8;TRIM5;MTMR1;TESC;SNX1;SCARB2;PRKRA;WARS1;BNIP3;CAMK2G;MAP3K9;CEP57;MIGA1;KYAT1;DCK;EXT2;ALS2;TERF2;DARS2;TYW5;LPL
prerank,semaphorin receptor activity (GO:0017154),-0.4350998695870514,-1.076131257639259,0.3627906976744186,0.7695224665295063,1.0,2/11,1.37%,PLXNA2;PLXNA4
prerank,protein tyrosine kinase binding (GO:1990782),0.35881658247599113,1.0739457496026497,0.3523447401774398,1.0,1.0,8/71,5.33%,LRP4;CEACAM1;SOCS5;CDH5;ITGAX;TJP2;PTPN14;BANK1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.44590123692839856,-1.0738693566502207,0.37969094922737306,0.7688102091072838,1.0,3/10,2.73%,SLC24A3;SLC8A3;SLC8A1
prerank,mRNA 3'-UTR binding (GO:0003730),0.34917835717281903,1.0707703499993002,0.358974358974359,1.0,1.0,17/79,15.60%,HNRNPC;FXR2;DND1;CELF1;HNRNPA0;SECISBP2;PABPC4L;PABPC4;TUT1;IGF2BP2;ELAVL2;CELF2;ILF3;ZFP36L2;FXR1;PUM2;CPEB3
prerank,pseudouridine synthase activity (GO:0009982),0.4755473790828632,1.068777970014637,0.39316239316239315,1.0,1.0,3/13,6.98%,RPUSD2;PUS7;PUS3
prerank,phospholipase binding (GO:0043274),0.4695300173168664,1.0672178602809332,0.3920552677029361,1.0,1.0,6/13,20.41%,SRC;PAFAH1B1;SYK;BTK;PDPK1;PRKN
prerank,WW domain binding (GO:0050699),-0.3439778071949578,-1.0669654907216233,0.3713450292397661,0.7815848533362745,1.0,3/26,4.00%,RAPGEF2;TNK2;LITAF
prerank,lysophospholipase activity (GO:0004622),-0.36934705411662827,-1.0663623815136778,0.3730886850152905,0.7764630873695499,1.0,5/20,14.11%,ENPP2;LYPLA1;ASPG;PNPLA6;LYPLAL1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.342099521342908,-1.0657660137449219,0.34294871794871795,0.7715770697214198,1.0,11/27,26.20%,MED21;POLR3B;POLR3A;POLR3H;POLR2F;POLR2A;POLR2J;POLR2D;POLR1C;POLR1F;POLR2I
prerank,ion channel inhibitor activity (GO:0008200),0.39587596595002417,1.0652865226478312,0.3791130185979971,1.0,1.0,7/35,12.30%,NEDD4L;CAMK2D;STX1A;FKBP1B;VAMP8;NEDD4;ENSA
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.4639304470022406,1.0629176351370782,0.3950413223140496,1.0,1.0,3/15,7.04%,SLC4A3;SLC26A9;SLC4A11
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.39116316418514235,1.0625042000012817,0.3687074829931973,1.0,1.0,15/37,23.87%,RARS2;TARS2;VARS1;CARS2;DARS1;KARS1;WARS1;WARS2;DARS2;TARS1;SARS2;HARS2;TARS3;MARS2;PARS2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.41752444215425,-1.0624657130859332,0.38164251207729466,0.7745821275447555,1.0,6/13,20.04%,SLC7A1;SLC7A6;SLC15A4;SLC38A7;SLC38A5;SLC25A29
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.46535352366148164,1.0624363766017126,0.38301282051282054,1.0,1.0,9/15,20.75%,SOCS5;SOCS6;PIK3R2;SOCS4;SOCS7;CCKBR;SOCS1;SOCS2;CISH
prerank,general transcription initiation factor binding (GO:0140296),-0.3490577605622477,-1.0609027759227885,0.35777126099706746,0.7725484294746463,1.0,10/25,28.83%,RUVBL1;AR;ESR1;DRAP1;AHR;HHEX;DR1;PSMC5;TAF11;THAP7
prerank,chemorepellent activity (GO:0045499),-0.34077660659825254,-1.058459943557666,0.3617021276595745,0.7730175287629807,1.0,5/25,5.19%,EPHA7;SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,dipeptidyl-peptidase activity (GO:0008239),0.49242803848304445,1.058263426202258,0.4153846153846154,1.0,1.0,3/10,7.89%,FAP;NAALAD2;DPP4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4351359660950466,1.0578940687267537,0.4045307443365696,1.0,1.0,4/21,6.68%,CDK15;CDKL3;CDK13;CDK7
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4351359660950466,1.0578940687267537,0.4045307443365696,1.0,1.0,4/21,6.68%,CDK15;CDKL3;CDK13;CDK7
prerank,ion channel activity (GO:0005216),0.34229059901002346,1.0566344426318088,0.3790123456790123,1.0,1.0,11/80,9.86%,PIEZO2;NALCN;TRPM3;GRIA3;TRPV4;TMC2;CNGB1;PIEZO1;GRID1;TMC4;GRIA1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.48300794352178794,1.0554645172827535,0.42470389170896783,1.0,1.0,2/11,1.41%,ITPR2;ITPR3
prerank,poly(U) RNA binding (GO:0008266),0.4344311473971062,1.0545724041300497,0.40764331210191085,1.0,1.0,4/20,7.87%,HNRNPC;PABPC4L;PABPC4;DIS3L2
prerank,histone acetyltransferase activity (GO:0004402),0.39256054821944497,1.0545157275575907,0.38002980625931443,1.0,1.0,11/30,19.22%,HAT1;KAT6B;TAF10;NCOA3;CREBBP;KAT8;EPC2;TADA2A;MCM3AP;NAA40;NAA60
prerank,pyridoxal phosphate binding (GO:0030170),-0.3667618355951458,-1.052500912597785,0.3785310734463277,0.7831936799399634,1.0,13/20,35.47%,PDXK;CBS;PYGB;ACCS;AGXT;CTH;OAT;PNPO;PYGL;THNSL2;SHMT2;SHMT1;PYGM
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.39215202616606787,1.052120938759523,0.40392706872370265,1.0,1.0,11/34,10.07%,ARHGAP9;ARAP1;OGT;PHLDA3;RACGAP1;KIF16B;ZFYVE16;OBSCN;GAB2;MAPKAP1;FERMT2
prerank,chemokine receptor activity (GO:0004950),0.41329640979226956,1.049486519135492,0.4080370942812983,1.0,1.0,1/24,0.78%,ACKR3
prerank,endopeptidase activity (GO:0004175),0.3020159518836214,1.0494000723740764,0.3753910323253389,1.0,1.0,50/257,17.26%,ADAMTS14;CORIN;MMP28;CTRC;ADAMTS12;ADAMTSL5;FAP;KLK2;ADAMTS1;PCSK5;ADAM19;MMP15;CD5L;ADAMTS19;USP8;ADAM10;ADAMTS2;DPP4;USP48;PSMB5;PCSK7;BACE2;USP47;USP13;MMP12;MME;PROC;CELA1;TASP1;KDM8;MMP16;ADAMTSL4;USP15;MIPEP;HTRA2;PSMB2;PSMA2;PSMA6;USP35;PLG;TYSND1;PSMA7;NLN;ZMPSTE24;ADAMTS20;BACE1;MBTPS1;MMP14;MASP2;USP37
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.2617367126741707,-1.0490549542383396,0.31313131313131315,0.785747590515154,1.0,19/78,17.69%,CTSH;USP28;CAPN15;USP1;CTSL;USP42;USP20;CASP3;CFLAR;USP18;LGMN;USP33;CASP12;USP36;USP30;CASP6;CASP8;CTSC;CASP4
prerank,lipid phosphatase activity (GO:0042577),0.4469750154979564,1.0459259523695659,0.41515650741350907,1.0,1.0,2/14,4.15%,PLPP2;PLPP3
prerank,steroid hydroxylase activity (GO:0008395),0.4508093170663559,1.0450161419514978,0.4255663430420712,1.0,1.0,2/16,3.79%,CYP7B1;CYP2S1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.345973827903116,1.042809208240017,0.4050955414012739,1.0,1.0,16/69,15.84%,MOGAT2;CERS6;MOGAT3;AWAT2;KAT6B;PLAAT5;ZDHHC1;SOAT1;ZDHHC7;ZDHHC13;CREBBP;ZDHHC20;KAT8;ZDHHC8;NAA10;NMT1
prerank,phosphotyrosine residue binding (GO:0001784),-0.3082909529394233,-1.0420891032270947,0.41216216216216217,0.798163833420097,1.0,10/37,12.62%,PTPN3;PIK3R1;PIK3R3;SHE;PLCG2;CRK;CRKL;LDLRAP1;BCAR3;SAMSN1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3300475986716549,-1.0399002099362766,0.3730407523510972,0.7978681804401601,1.0,13/28,28.14%,TNK2;RPS6KB1;MAP2K2;AKT1;LRRK2;MAP2K3;MAPKAPK3;MAP2K6;RPS6KA1;MAP2K1;TTK;MAP2K4;MAP2K5
prerank,potassium channel regulator activity (GO:0015459),0.36734480043388523,1.0392404560686719,0.4050131926121372,1.0,1.0,12/49,20.30%,NEDD4L;KCNIP4;KCNS3;KCNAB1;SGK1;SLC5A3;ENSA;YWHAE;CHP1;SUMO1;ADRB2;KCNIP1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.35465605580609244,-1.0372202513560946,0.42382271468144045,0.7988064081236722,1.0,4/20,6.86%,SLC30A10;SLC39A10;SLC39A8;SLC39A14
prerank,actin binding (GO:0003779),0.30850390335974953,1.0322291111281168,0.4094922737306843,1.0,1.0,25/170,10.66%,UTRN;SORBS1;PARVA;PRKCE;COBL;CEACAM1;TLN2;PDLIM4;SPEF1;CAPZB;TRPV4;ADD1;PPP1R42;SHROOM2;ABL2;RDX;DAG1;TMOD1;MICAL3;CALD1;FLNB;CGN;FERMT2;GC;MTSS1
prerank,DNA binding (GO:0003677),0.2884616123436384,1.0300874263749669,0.3895582329317269,1.0,1.0,131/694,17.96%,RORA;MEOX2;NFATC2;GLI1;PPARGC1A;FOXD2;NR2F2;TSHZ3;RARB;FOXP2;ZNF423;FOXD1;ZBTB32;KLF12;PBX1;EGFR;MYBBP1A;ETV5;TDG;MSH6;NUFIP1;COLEC11;HIVEP2;GLI2;TFPT;CHD3;PCBP2;HLX;FOXO3;SOX9;PGR;WDR76;NPAS2;CHD8;HDAC4;CHD2;SATB1;NTHL1;BANF2;SMARCAD1;PDS5B;TSG101;GTF3C6;TAF4B;RFC3;ARID3A;STN1;NBN;ZDHHC1;C1D;SIRT3;CTCF;HIC1;PALB2;PAX3;TBX2;MSH2;MSL3;USF2;ILF2;RBM5;FOXK2;JRKL;ZBTB6;TET1;SLTM;MECP2;FOXJ1;HMGB1;ZMYM6;POU4F1;HDAC2;TRNP1;ERCC6;LONP1;MMP12;ILF3;SAP30L;RARG;EGR1;ERCC1;TDP1;ZBTB49;ZNF148;TOP1;ERF;MEN1;INO80;NFE2L2;MTERF2;POGK;CRLF3;CREBBP;ARID4A;NUCKS1;SFPQ;GTF3C5;MBD1;CBFB;RAD51AP2;POLG2;CAMTA2;REXO4;FOXF1;NR5A1;POU6F1;FAM111A;DEDD;AIFM2;POLE;FOXC2;KMT2D;DDB2;PBX4;SRRT;TSNAX;BATF;E2F1;QRICH1;ESRRA;HP1BP3;PPARG;RTF1;CUL4B;MTF2;TDP2;BRIP1;ORC1;CREM;RFC1;SYCP2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3826060157885146,1.0281520979244663,0.41853932584269665,1.0,1.0,18/33,26.43%,ZNF326;RPRD1B;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;ERBB2;SPTY2D1;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;HNRNPU
prerank,TBP-class protein binding (GO:0017025),-0.3501467919138489,-1.0273678816651168,0.42391304347826086,0.8196225624477752,1.0,8/21,27.75%,RUVBL1;ESR1;DRAP1;AHR;HHEX;DR1;PSMC5;TAF11
prerank,GTPase activity (GO:0003924),0.30232212911296796,1.0272425863030883,0.41883116883116883,1.0,1.0,19/192,8.98%,GNA14;RAP1A;RAB8B;RAB29;MRAS;BMS1;GNAQ;MFN2;DNM1;RAC2;NRAS;KRAS;RHOJ;RAB3A;GNL2;ATL2;IRGM;GNG3;GNAL
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.45940307853003387,1.0253113699245293,0.41989881956155145,1.0,1.0,4/13,11.28%,GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,phospholipase activity (GO:0004620),0.34014404299970524,1.0222351869913384,0.4262899262899263,1.0,1.0,8/67,8.30%,PLCE1;PLCB3;DDHD1;GPLD1;PLCL1;PLAAT5;PLD3;ABHD12
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.36898084431639067,1.0204284399344399,0.4315352697095436,1.0,1.0,3/38,4.90%,SERPINB2;SERPING1;SERPINH1
prerank,FMN binding (GO:0010181),0.4777816604496513,1.0186597370381176,0.4522058823529412,1.0,1.0,1/11,0.66%,POR
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3896122254679463,-1.0184338099524175,0.4387755102040816,0.8368611022016792,1.0,4/14,9.30%,SLC26A7;SLC26A2;SLC25A30;SLC25A11
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.3634102370621686,-1.0180827646939505,0.43640897755610975,0.831421140492879,1.0,5/17,9.11%,GRIA2;GRIN3A;GRIN2B;GRIK2;GRIN1
prerank,magnesium ion binding (GO:0000287),0.31224371079537017,1.0172856422538636,0.43314285714285716,1.0,1.0,41/135,20.42%,XYLT2;TDG;MSH6;STK38;IRAK3;THTPA;BRSK1;DXO;CERK;ABL2;NLRC4;STK38L;CLYBL;MSH2;MAP3K5;DIS3L2;PGM1;SRPK1;FOXK2;PLSCR1;STK3;SRPK2;NUDT18;GEN1;PRKACB;SIK3;ADPRS;ERN1;NT5C3A;RAN;PI4K2A;TESC;GEM;DYRK2;TDP2;PINK1;CDC42BPG;NME1;NUDT5;TKT;SIK2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.43287310169608956,-1.0143018538376525,0.44469525959367945,0.8356042526886862,1.0,3/10,19.57%,SETD5;SMYD2;ASH1L
prerank,kinase activity (GO:0016301),-0.24097422807325436,-1.012330201401413,0.4122137404580153,0.8347680192453119,1.0,26/109,14.92%,NADK2;CHKA;LYN;EPHA4;PDXK;CKB;PGM2L1;PAPSS1;ETNK1;AKT1;CAMK2A;PIK3C2A;DGKB;CDKL5;FCSK;PANK1;LRRK2;PMVK;CSNK2A1;IPMK;SPHK1;CDC7;DGKK;MVK;SEPHS1;CDK5R1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.44022097107795805,1.0118831255086154,0.42495784148397975,1.0,1.0,4/15,11.28%,GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3325013717673033,1.0116198491369575,0.4419475655430712,1.0,1.0,3/73,3.10%,SORCS2;KISS1R;MC5R
prerank,sodium channel activity (GO:0005272),0.3675661799010826,1.0104400928814898,0.43564356435643564,1.0,1.0,5/37,7.04%,SCN10A;KCNK1;CACNA1H;SHROOM2;SLC4A11
prerank,histone demethylase activity (GO:0032452),-0.31976223909866464,-1.0100755344978651,0.4420731707317073,0.834776594720619,1.0,6/27,12.83%,KDM5C;PHF8;KDM2B;JARID2;KDM1A;KDM7A
prerank,adrenergic receptor binding (GO:0031690),-0.37196106933447215,-1.0090688794464844,0.4656084656084656,0.8309529486086316,1.0,2/16,1.05%,RAPGEF2;GNAS
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.4509020027350852,1.008719278682443,0.4469820554649266,1.0,1.0,3/13,4.65%,CDH5;SRC;BMP5
prerank,RNA stem-loop binding (GO:0035613),-0.40206710517035255,-1.0086008630176697,0.48847926267281105,0.8260305684264148,1.0,5/12,18.06%,LARP6;MYH10;ZC3H12A;RC3H1;METTL16
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.271384617882422,-1.0084497826379202,0.45121951219512196,0.8203105103794474,1.0,8/55,6.32%,SLC24A3;ITPR1;TRPC3;TRPC1;ANXA2;CACNB2;ORAI1;ATP2C1
prerank,metallopeptidase activity (GO:0008237),0.31640830982507967,1.0071761050953776,0.45346062052505964,1.0,1.0,24/113,17.49%,ADAMTS14;MMP28;ADAMTS12;ADAMTSL5;ADAMTS1;ADAM19;BRCC3;MMP15;ADAMTS19;RNPEP;ADAM10;ADAMTS2;LNPEP;MMP12;MME;MMP16;ADAMTSL4;MIPEP;COPS5;NLN;ZMPSTE24;ADAMTS20;MMP14;BMP1
prerank,poly-pyrimidine tract binding (GO:0008187),0.3994203936327087,1.0062009299063444,0.44254658385093165,1.0,1.0,4/23,7.87%,HNRNPC;PABPC4L;PABPC4;DIS3L2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.39755051320773754,1.0055481028186575,0.4496240601503759,1.0,1.0,11/24,22.43%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,outward rectifier potassium channel activity (GO:0015271),-0.3993600295513486,-1.0054535234912374,0.4766146993318486,0.8225735252119116,1.0,2/11,6.28%,KCNK2;KCNT1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.4526435965204637,1.0044847984707281,0.45058626465661644,1.0,1.0,1/12,1.29%,SULF1
prerank,copper ion binding (GO:0005507),-0.2913050460855992,-1.0031619514934311,0.4412811387900356,0.8227028693665767,1.0,5/42,5.38%,MOXD1;ATP7A;COMMD1;LACC1;SOD3
prerank,palmitoyltransferase activity (GO:0016409),0.3914207604866922,1.0026896662293252,0.453030303030303,1.0,1.0,13/28,22.52%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7;ZDHHC5
prerank,ribonuclease P activity (GO:0004526),0.46173662382960057,1.0023487523965513,0.48853615520282184,1.0,1.0,6/11,24.93%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2925883165980934,1.0008087666605638,0.44880174291938996,1.0,1.0,52/188,21.86%,BNC2;GLI1;PBX1;ZBTB20;ETV5;CHD3;SPI1;FOXK1;FOXO3;GLIS2;HDAC4;CREB3L1;CTCF;NCOR1;LIN54;SUV39H1;FOXK2;TBX18;FOXJ1;HMGB1;TFEB;EGR1;MZF1;MEN1;NFE2L2;ARID4A;SOX4;SFPQ;ERBB4;FOXC2;YAP1;KMT2D;PER3;DMTF1;PSPC1;TFE3;MTERF3;PPARG;SUV39H2;GABPA;XRCC6;DHX9;CREB3L2;DDIT3;TAF2;ASH2L;PAX2;RUNX1;ZBED4;FOXC1;TCF7L2;JUN
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.45718502777726083,0.9999976933722161,0.46440677966101696,1.0,1.0,2/12,6.79%,OPN1MW;OPN1MW3
prerank,neurexin family protein binding (GO:0042043),0.4706935947914955,0.9997463908498146,0.4652777777777778,1.0,1.0,2/10,4.70%,CEL;CPE
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3464091612747277,0.9967719292420528,0.45272969374167776,1.0,1.0,12/49,11.27%,TNIP3;BRCC3;WDR81;TNFAIP3;UBL7;TNIP1;UIMC1;MINDY2;SHARPIN;OTUD7B;TAB2;HDAC6
prerank,tau-protein kinase activity (GO:0050321),-0.3455153633542675,-0.9949492378432915,0.44744744744744747,0.8378580405621863,1.0,5/20,12.54%,ROCK2;MARK1;GSK3A;TTBK1;TAOK2
prerank,solute:anion antiporter activity (GO:0140323),-0.384701805933231,-0.9919529628453212,0.4583333333333333,0.8395666605481602,1.0,3/14,6.77%,SLC7A11;SLC26A7;SLC26A2
prerank,RNA polymerase II complex binding (GO:0000993),0.3712064941566791,0.9913612781490087,0.4656160458452722,1.0,1.0,16/32,26.43%,ZNF326;RPRD1B;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;HNRNPU
prerank,proton transmembrane transporter activity (GO:0015078),0.35711201878852755,0.9890160670069823,0.4958217270194986,1.0,1.0,8/39,15.52%,OTOP1;COX5A;SLC4A11;COX15;NNT;COX5B;SLC46A1;CLCN5
prerank,ribonuclease P RNA binding (GO:0033204),0.4629785763416243,0.9885375026782978,0.5035971223021583,1.0,1.0,5/10,23.14%,POP4;POP7;RPP14;RPP21;RPP30
prerank,BMP receptor binding (GO:0070700),0.4509049146965599,0.9880932508242007,0.4822934232715008,1.0,1.0,3/12,4.65%,CDH5;SRC;BMP5
prerank,nucleoside-triphosphatase activity (GO:0017111),0.28659231378136935,0.9874776911737942,0.5010593220338984,1.0,1.0,25/248,8.98%,GNA14;KIF2A;RAP1A;RAB8B;RAB29;MRAS;KIF20B;CHD3;BMS1;VWA8;GNAQ;MFN2;DNM1;RAC2;THTPA;NRAS;KRAS;KIF3C;RHOJ;RAB3A;GNL2;ATL2;IRGM;GNG3;GNAL
prerank,deubiquitinase activity (GO:0101005),0.3179147437959585,0.985989285738008,0.47869674185463656,1.0,1.0,24/88,18.82%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;USP48;MINDY3;MINDY2;USP47;PAN2;USP13;OTUD7B;MINDY4;USP15;USP4;USP35;COPS5;STAMBPL1;STAMBP;USP45;USP53;USP37;PSMD14;USP9X
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3641790706232009,0.9857710957895814,0.47782546494992845,1.0,1.0,18/33,26.43%,ZNF326;RPRD1B;LLPH;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;TBP;HNRNPU
prerank,GTPase regulator activity (GO:0030695),0.2913876563027196,0.9856554278078332,0.5118790496760259,1.0,1.0,20/212,6.44%,ARHGAP42;SIPA1L1;DLC1;RGS6;RGS14;ARHGAP31;ARHGAP18;ARHGAP32;GRTP1;ARHGAP9;ARAP1;DOCK1;SGSM2;NF1;OPHN1;RACGAP1;GNAQ;GDI1;ARHGAP26;RAB3GAP2
prerank,chemokine binding (GO:0019956),0.3715761101825203,0.9850589682548042,0.48104956268221577,1.0,1.0,5/30,21.17%,ACKR3;HMGB1;CCR5;ITGB1;CX3CR1
prerank,endopeptidase regulator activity (GO:0061135),0.3596153385200295,0.9832675505308491,0.49644381223328593,1.0,1.0,4/40,6.99%,SPINK1;APH1B;PSME3;NLRC4
prerank,receptor tyrosine kinase binding (GO:0030971),0.33742585400622915,0.9824392505011875,0.48058902275769744,1.0,1.0,8/56,10.34%,LRP4;SOCS5;ITGAX;PTPN14;TRADD;PIK3R2;GAB2;CBLB
prerank,anion channel activity (GO:0005253),0.33265594993240244,0.9819975029934992,0.4695201037613489,1.0,1.0,9/61,12.26%,VDAC2;LRRC8D;SLC26A9;ANO6;GABRR2;GABRG2;BEST1;GABRG1;GABRB3
prerank,protein kinase C activity (GO:0004697),0.4355542206688012,0.981879610380351,0.4879310344827586,1.0,1.0,2/14,4.28%,PRKCE;PRKCA
prerank,UDP-galactosyltransferase activity (GO:0035250),0.46341857415866616,0.9818692332363723,0.48713550600343053,1.0,1.0,2/10,5.84%,B3GALT1;A3GALT2
prerank,MAP kinase phosphatase activity (GO:0033549),-0.39012125837002537,-0.9812693121542297,0.4987405541561713,0.8627015057183907,1.0,4/12,21.90%,DUSP10;DUSP3;DUSP7;DUSP1
prerank,methyl-CpG binding (GO:0008327),-0.3231298375662508,-0.9797383915490153,0.4604105571847507,0.8606261871733536,1.0,5/22,13.18%,ZBTB38;CXXC5;WDR77;ZBTB21;LRWD1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4515394322236047,0.9788520887999197,0.5072463768115942,1.0,1.0,3/11,10.61%,AKR1B10;RDH14;RDH13
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.38590030973829154,-0.9782757050800426,0.45365853658536587,0.8586419814587419,1.0,6/12,17.46%,CDK12;CDK9;CDK6;CDK8;CDK4;CDK19
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3883058809772148,0.9780201848825135,0.48721804511278194,1.0,1.0,9/25,10.01%,PHLDA3;SESTD1;KIF16B;PLEKHA4;OBSCN;TTPA;PLEK;GAB2;MAPKAP1
prerank,ubiquitin protein ligase binding (GO:0031625),-0.20483506273559035,-0.9767637950614372,0.5,0.8570542283344185,1.0,60/254,16.39%,SNCAIP;SMAD3;FZD6;TXNIP;SMAD6;MFHAS1;FOXO1;CKB;TNK2;CCDC50;SQSTM1;SMAD5;RBX1;TRIOBP;HIF1A;BECN1;SPOP;TNFRSF1B;HSPA8;GABARAPL1;DNAJA1;ARIH1;TRAF6;UBE2N;NEDD8;DBT;SLF2;UBE2K;ACTG1;BCL10;ATP6V0C;NAE1;VCP;GPR37;GABARAP;SLF1;SLC22A18;TRIM28;UBE2J1;TPI1;TRIB1;RPL23;ANKRA2;RNF31;AMBRA1;CUL2;RAD18;BAG4;PRKAR2B;HERC2;ERLIN2;YWHAZ;NKD2;FZD8;ISG15;RNF8;TRIM37;LAPTM5;SMC6;CBS
prerank,cytokine activity (GO:0005125),0.29923684415587015,0.9737599086460625,0.5028968713789108,1.0,1.0,9/131,5.38%,INHBB;IL19;WNT10A;WNT2B;IL1A;WNT16;BMP5;WNT5A;BMP15
prerank,chemokine receptor binding (GO:0042379),-0.28453297333169697,-0.9728421964661739,0.49666666666666665,0.8612171089406271,1.0,25/35,52.22%,CXCL16;CXCL12;CCL13;CCL19;CCL2;CXCL10;CCL25;CCL28;CCRL2;CCL5;CXCL5;CCL11;CCL15;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.44870925353767505,0.9707555276779919,0.4965753424657534,1.0,1.0,6/10,28.38%,GLCE;RPE;DSE;GNE;DSEL;RENBP
prerank,histone deacetylase activity (GO:0004407),0.39636507721408576,0.9701322035276799,0.4933530280649926,1.0,1.0,5/19,11.27%,HDAC4;SIRT3;SIRT7;HDAC2;HDAC6
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.2960281849039864,-0.9698055748557278,0.5014925373134328,0.8633984362394176,1.0,7/33,10.31%,RNF217;RNF125;ARIH1;TRAF6;RNF144B;UBA2;RPS3
prerank,protein serine/threonine kinase activity (GO:0004674),0.277671031150626,0.9695857801630715,0.56,1.0,1.0,43/334,9.79%,PLK2;FAM20C;CDK15;PRKCE;CAMK2D;EGFR;MINK1;CLK1;STK38;MAP3K1;CASK;MAPK10;EIF2AK3;BMPR1B;PRKCA;CDKL3;LIMK2;IRAK3;ACVR1C;TRIO;HIPK1;PIK3R4;BRSK1;NEK7;CDK13;BCKDK;CDK7;BMP2K;CLK4;STK38L;MAPK7;MAP3K5;SRPK1;DYRK1A;NRBP2;KALRN;CSNK1G3;STK24;STK3;GSK3B;RPS6KA3;MASTL;CSNK1A1
prerank,low-density lipoprotein particle binding (GO:0030169),0.4131851586755939,0.969116955758597,0.4965635738831615,1.0,1.0,1/16,0.50%,CDH13
prerank,anion:anion antiporter activity (GO:0015301),0.41754707224371745,0.9689098195333449,0.5051020408163265,1.0,1.0,2/17,2.36%,SLC4A3;SLC26A9
prerank,chloride transmembrane transporter activity (GO:0015108),-0.35192796023083117,-0.9668098809673951,0.49230769230769234,0.8655799761259996,1.0,4/16,13.71%,SLC26A7;SLC26A2;SLC12A5;SLC1A1
prerank,carboxypeptidase activity (GO:0004180),0.3605953012035627,0.9639896576736138,0.5154494382022472,1.0,1.0,7/35,9.67%,NAALAD2;AGBL4;CPE;CPA2;SCPEP1;BLMH;MINDY2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.20010058845613107,-0.9626924839688868,0.8,0.8709299650510164,1.0,119/431,21.53%,PRKAG2;DAPK1;KSR1;RHOBTB1;INSR;MYO1B;ENPP1;MAP3K20;MARK1;LATS2;TGM2;CDC42;MTHFS;SNRK;TGFBR1;MFHAS1;AKT3;ATP7A;PDXK;ACVRL1;RPS6KA5;STK17B;RHOBTB3;SIK1;EEF1A1;BLM;MMAA;SMC4;TRNT1;HSPA8;TWF1;GBP3;HARS1;ABCC6;GBP4;MCM6;RHOC;ABCD4;GCH1;CDK6;UBA2;TAP2;SYN1;MKNK2;AKT1;MYH10;GTPBP10;RAB13;CDKL5;VPS4A;TUBB2A;RRAGC;RHOH;RHOB;TRIB1;MKNK1;GBP6;OXSR1;LRRK2;ACLY;ABCD2;PMVK;ABCE1;ABCA2;PXK;SMARCA5;GBP7;SPHK1;MYO18A;SYN3;TUBB6;REM1;MTHFD1L;TUBB4B;ABCG1;RRAGD;MVK;SEPHS1;MTPAP;P2RX7;NOA1;HACL1;PEX6;GBP2;TUBB4A;P2RX4;EIF4G1;ARF5;ANXA6;NOL9;PEX1;RERG;ARL2;TSR1;DHX36;RHOT1;CLP1;RAB4A;DIRAS2;RAB11B;MYH9;KCNJ8;RHOF;PIM1;GNL3;TUBA1C;RAB32;DAPK3;PFKM;RAB2A;TUBA4A;DYNC1LI1;TUBB2B;SYN2;ARF3;RAB7A;RIT1;HRAS;PANK3
prerank,exoribonuclease activity (GO:0004532),0.4289371114126987,0.9618114560957337,0.4948805460750853,1.0,1.0,3/12,9.99%,EXOSC5;EXOSC10;CNOT7
prerank,microtubule motor activity (GO:0003777),0.3332019116052014,0.9604663224070068,0.4966532797858099,1.0,1.0,10/51,13.61%,KIF2A;KIF20B;SMC3;KIF16B;KIF7;KIF3C;KIF13A;KIF26A;KIF5A;KIF5B
prerank,protein phosphatase 2A binding (GO:0051721),-0.3174068100802135,-0.9583538165282273,0.5440729483282675,0.8766974941584672,1.0,7/23,14.31%,MFHAS1;FOXO1;CTTNBP2NL;GRIN3A;IGBP1;SPHK1;MAPT
prerank,ribosomal small subunit binding (GO:0043024),-0.34097034601582465,-0.9581197447472964,0.52,0.8713370280256536,1.0,9/17,28.27%,NPM1;CPEB2;MTIF2;ABCE1;PIM1;EIF1B;DHX29;ERAL1;DDX3X
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.30692237361695035,-0.9579597096441084,0.5277777777777778,0.8659967750297672,1.0,5/27,7.26%,RNF217;RNF125;ARIH1;TRAF6;RNF144B
prerank,sodium:proton antiporter activity (GO:0015385),-0.40204114072452357,-0.957016188689637,0.546875,0.8626331270615982,1.0,5/11,18.66%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,hyaluronic acid binding (GO:0005540),-0.41040648348758413,-0.956177672858817,0.5136986301369864,0.8589668671654973,1.0,4/10,25.90%,LAYN;C1QBP;LYVE1;CHODL
prerank,protein kinase C binding (GO:0005080),-0.26844358100066595,-0.9558838200493834,0.527972027972028,0.8539916566365562,1.0,19/43,24.20%,GRK5;PARD6G;SQSTM1;HDAC7;HDAC9;ADCY4;PDLIM5;DACT2;HSPB1;HINT1;RACK1;PICK1;CAVIN3;NELL1;TOP2B;TOP2A;ADCY6;PRKCB;DSP
prerank,ribonuclease activity (GO:0004540),0.32597204224776705,0.9555694492127784,0.5261744966442953,1.0,1.0,16/56,23.67%,PIWIL2;EXOSC5;N4BP1;DIS3L2;AGO1;EXOSC10;CNOT7;EXOG;ERN1;DICER1;TSNAX;RNASE3;EXOSC7;SMG6;RNASE1;RNASEH1
prerank,cytochrome-c oxidase activity (GO:0004129),0.4117331452628283,0.9540504846419834,0.5016722408026756,1.0,1.0,3/15,13.18%,COX5A;COX15;COX5B
prerank,"DNA binding, bending (GO:0008301)",0.4246333395232709,0.9536602833164538,0.5218800648298217,1.0,1.0,3/14,11.05%,FOXD1;HMGB1;SAP30L
prerank,tubulin binding (GO:0015631),0.27461673018123584,0.9521178851342578,0.5884177869700103,1.0,1.0,63/295,17.35%,DLEC1;RGS14;GTSE1;HOOK2;KIF2A;SPEF1;KIF20B;TTLL1;TRPV4;RACGAP1;FAM83D;AGBL4;DNM1;SMC3;KIF16B;CAPN6;BRSK1;KIF7;PPP1R42;IFT81;SPAST;KIF3C;DAG1;CKAP5;SGIP1;KIF13A;PAFAH1B1;EML1;FNTA;REEP3;IFT74;TUBGCP5;TPR;S100A9;APC;HDAC6;HOOK3;MAP4;CCDC170;RAB11FIP5;NDE1;MAP9;INO80;ARL8B;KIF26A;KIF5A;MAPRE2;EMD;KIF5B;HTT;POLB;FAM161A;CRIPT;TBCE;EZR;B9D2;SYBU;ARHGEF7;TTLL9;AGBL1;CEP57;CHP1;SETD2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.43586058368856617,0.9514950814193828,0.5136986301369864,1.0,1.0,1/11,1.41%,ITPR3
prerank,snoRNA binding (GO:0030515),0.3629460732625785,0.9495598259514516,0.5093525179856115,1.0,1.0,6/30,12.72%,NUFIP1;BMS1;NOP14;SNU13;NOP56;NOP58
prerank,bHLH transcription factor binding (GO:0043425),-0.32946166910158814,-0.9487061555938423,0.5423280423280423,0.8661708108981603,1.0,5/19,12.56%,SMAD3;LMO2;MAP3K10;KDM1A;SP1
prerank,sequence-specific mRNA binding (GO:1990825),-0.39423050760926315,-0.9484591466098009,0.5458823529411765,0.8611424535710727,1.0,5/10,28.00%,SSB;LARP6;DHFR;SHFL;RBM24
prerank,E-box binding (GO:0070888),-0.27633437317870974,-0.9447648260845283,0.5394321766561514,0.8651912647536529,1.0,2/34,3.98%,TCF4;MITF
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.4308450624926893,0.9443178158353267,0.5241379310344828,1.0,1.0,2/11,5.22%,SLC22A3;SLC25A20
prerank,cyclic nucleotide binding (GO:0030551),-0.31555576401450225,-0.943598967892602,0.5534246575342465,0.8624790225674315,1.0,6/21,12.95%,RAPGEF2;PDE5A;KCNH1;PDE10A;PDE2A;PDE4A
prerank,protein kinase binding (GO:0019901),0.26800101115797226,0.9422880346184478,0.640973630831643,1.0,1.0,62/479,11.32%,ROR2;CAV1;TRIB2;UTRN;CSPG4;CEACAM1;CNKSR2;SLC12A2;CCND3;FAM83A;KCNA5;GYS1;NELL2;AXIN1;PARD6B;CDH5;STK38;MAP3K1;SPRED1;TRPV4;TJP2;CAV2;RACGAP1;PRKAG1;FOXO3;SOX9;SLC12A4;FAM83D;HNRNPA0;DNM1;RAC2;IRAK3;DACT1;PTPRC;IBTK;BANK1;TOM1L1;ANKRD2;ADAM10;TRIM21;SRCIN1;MSH2;MAPK7;RARA;FBXO5;PRKAR2A;PTPRJ;TNIP1;TEX14;IRGM;PLEK;GSK3B;TOM1L2;TICAM1;MAPKAP1;FERMT2;LAT;ADRA2A;TPR;APC;PRKCSH;SPAG9
prerank,thiol-dependent deubiquitinase (GO:0004843),0.30542617939044586,0.9421579834722875,0.5525982256020279,1.0,1.0,22/83,18.82%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;USP48;MINDY3;USP47;PAN2;USP13;OTUD7B;USP15;USP4;USP35;COPS5;STAMBPL1;STAMBP;USP45;USP53;USP37;PSMD14;USP9X
prerank,amino acid:sodium symporter activity (GO:0005283),0.44006167955991926,0.9419412990147429,0.53125,1.0,1.0,2/11,5.54%,SLC38A2;SLC6A13
prerank,adenylate cyclase binding (GO:0008179),0.4453762051008644,0.9395504203379162,0.5300353356890459,1.0,1.0,2/10,5.35%,AKAP12;ADCY5
prerank,calcium ion binding (GO:0005509),0.26801740960127707,0.9389853992949267,0.6168032786885246,1.0,1.0,29/323,9.06%,THBS4;SMOC2;CDH13;GUCA1A;ITPR2;ITPR3;CDH11;SLC25A12;GLCE;CDH5;ACER3;KCNIP4;COLEC11;CDH17;CDH9;TPD52;S100A6;NUCB1;CALR3;S100A7A;ANXA4;LTBP4;RCN1;CDH2;S100B;EML1;PLSCR1;CASQ2;CD320
prerank,hormone receptor binding (GO:0051427),0.4201880639985757,0.936109380466108,0.55,1.0,1.0,6/14,26.36%,PTHLH;TYK2;JAK1;SOCS2;ADCYAP1;CCK
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.2778754194289104,0.9355651163230871,0.6045503791982665,1.0,1.0,30/181,14.88%,MDFIC;PPARGC1A;NFATC1;LDB2;SPI1;HDAC4;DACT1;BHLHE40;TAF4B;ANKRD2;ANXA4;NRIP1;TEAD3;NCOR1;PIAS2;ISL1;DDRGK1;GSK3B;PTPRT;HDAC2;NCOR2;FAF1;NCOA3;NFE2L2;CREBBP;NCOA2;TCERG1;BAZ2A;PSMA6;WWP2
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.2755192021258373,-0.9350528666543301,0.5445859872611465,0.8781614633020177,1.0,8/35,18.12%,POU2F1;FOXP1;NPM1;HDAC1;DRAP1;TBPL1;DR1;TAF1C
prerank,filamin binding (GO:0031005),0.42592991856159207,0.932593320586588,0.5435540069686411,1.0,1.0,1/11,1.25%,CEACAM1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.38902850814297824,-0.9314778586287387,0.5521327014218009,0.8814120034184586,1.0,2/10,8.57%,PIK3R3;PIK3C2A
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.29079312685543335,-0.9310221156112979,0.603125,0.8770839832336697,1.0,2/29,1.72%,PRKAG2;PKIG
prerank,neuropeptide receptor binding (GO:0071855),0.41847546009620273,0.9299329302232815,0.5422297297297297,1.0,1.0,5/14,28.13%,APLN;AGRP;PPY;SHANK1;NPY
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.41958953032803487,0.9298452252724599,0.5402504472271914,1.0,1.0,2/12,9.70%,CYFIP2;EIF4E
prerank,miRNA binding (GO:0035198),0.35459031590533224,0.9293796358581023,0.557427258805513,1.0,1.0,13/30,25.78%,DND1;RBM10;ZNF346;AGO1;PUM2;SPOUT1;PUM1;ELAVL1;ZC3H7B;DDX21;FMR1;PNPT1;AGO2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.44007418539769133,0.9282351344803758,0.5533807829181495,1.0,1.0,5/10,19.22%,HAT1;MSL3;KAT8;NAA40;NAA60
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.37754331747934256,-0.9272620979001664,0.5662100456621004,0.881037666797595,1.0,5/12,18.66%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,carboxylic acid binding (GO:0031406),-0.2673177161724462,-0.9242867405213784,0.5876623376623377,0.8827999363619761,1.0,11/38,20.40%,UBR1;NOS3;GRIN3A;GRIN2B;GRIN1;GLRA2;MAG;NOS1;GCLC;CASTOR2;CASTOR1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2999045324905607,-0.9241625369996016,0.564179104477612,0.877626582345869,1.0,8/26,18.40%,AEBP1;FOLH1;AGBL5;CPXM2;CPD;CPA6;ACE2;VASH1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.19223430890102072,-0.9237944303544038,0.8095238095238095,0.8732128790055337,1.0,60/269,16.39%,SNCAIP;SMAD3;FZD6;TXNIP;SMAD6;MFHAS1;FOXO1;CKB;TNK2;CCDC50;SQSTM1;SMAD5;RBX1;TRIOBP;HIF1A;BECN1;SPOP;TNFRSF1B;HSPA8;GABARAPL1;DNAJA1;ARIH1;TRAF6;UBE2N;NEDD8;DBT;SLF2;UBE2K;ACTG1;BCL10;ATP6V0C;NAE1;VCP;GPR37;GABARAP;SLF1;SLC22A18;TRIM28;UBE2J1;TPI1;TRIB1;RPL23;ANKRA2;RNF31;AMBRA1;CUL2;RAD18;BAG4;PRKAR2B;HERC2;ERLIN2;YWHAZ;NKD2;FZD8;ISG15;RNF8;TRIM37;LAPTM5;SMC6;CBS
prerank,CCR chemokine receptor binding (GO:0048020),-0.28294955783965503,-0.9229151286349493,0.5825825825825826,0.8700309835200586,1.0,20/28,52.12%,NES;CCL13;CCL19;CCR2;CCL2;CCL25;CCRL2;CCL5;CCL11;CCL15;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,glycerophospholipid flippase activity (GO:0140333),0.426067804286139,0.9207848421862378,0.5502645502645502,1.0,1.0,4/11,9.88%,ATP8B1;ATP11C;ATP8B2;ATP10B
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.34689968563592477,0.9202922540745786,0.5583090379008746,1.0,1.0,7/34,16.02%,UBE2L6;UBE2E2;UBE2I;UBE2J2;UBE2D3;UBE2D1;UBE2R2
prerank,phosphatidylinositol binding (GO:0035091),0.29595280404521146,0.9192025061583422,0.6,1.0,1.0,7/91,6.96%,PIGU;ITPR2;ITPR3;PITPNC1;SESTD1;ZFYVE16;SNX10
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.2624219817719134,-0.918567033239539,0.60431654676259,0.8755093837888737,1.0,10/42,12.62%,PTPN3;PIK3R1;PIK3R3;SHE;PLCG2;CRK;CRKL;LDLRAP1;BCAR3;SAMSN1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3770916727342668,0.9177128680848707,0.5655487804878049,1.0,1.0,6/23,10.01%,PHLDA3;SESTD1;KIF16B;SH3PXD2B;PLEKHA4;MAPKAP1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.38784956683652055,0.9174500957596701,0.5570469798657718,1.0,1.0,3/16,12.31%,SLC29A4;SLC22A3;SLC25A26
prerank,nuclear export signal receptor activity (GO:0005049),0.4228937181877989,0.9171457711269552,0.5626072041166381,1.0,1.0,6/11,26.07%,CSE1L;RAN;XPO5;XPO4;XPO7;RANBP17
prerank,Notch binding (GO:0005112),-0.3027314428125954,-0.9126349683205025,0.5826086956521739,0.8842503307042828,1.0,6/22,9.65%,SNED1;CCN3;GALNT11;JAG2;KCTD10;SNW1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3681788403423506,-0.9109012398614708,0.5622222222222222,0.8832760165696603,1.0,5/11,23.68%,NUDT3;NUDT11;DCP2;NUDT16;NUDT16L1
prerank,MAP kinase activity (GO:0004707),-0.33050467585029913,-0.9108143058734849,0.5461741424802111,0.8781600235293927,1.0,2/14,6.92%,MAPK4;MAPK12
prerank,phospholipase activator activity (GO:0016004),0.4276893304774524,0.9094800717486896,0.5652920962199313,1.0,1.0,4/10,18.55%,SRC;BTK;STX4;PDPK1
prerank,metal ion binding (GO:0046872),0.257553281014025,0.9083941971331572,0.7340748230535895,1.0,1.0,52/477,9.22%,THBS4;SMOC2;CDH13;GUCA1A;ITPR2;ITPR3;CDH11;SLC25A12;XYLT2;GLCE;CDH5;ACER3;TDG;MSH6;KCNIP4;COLEC11;CDH17;STK38;CDH9;TPD52;HMGCLL1;S100A6;NUCB1;IRAK3;THTPA;ACVR1C;CALR3;BRSK1;DXO;S100A7A;ANXA4;CERK;ABL2;LTBP4;NLRC4;STK38L;CLYBL;MSH2;MAP3K5;RCN1;CDH2;DIS3L2;PGM1;SRPK1;S100B;EML1;FOXK2;RPE;PLSCR1;CASQ2;CD320;STK3
prerank,lipoprotein particle binding (GO:0071813),0.36849435509805595,0.9080122457086669,0.5548281505728314,1.0,1.0,1/20,0.50%,CDH13
prerank,heme binding (GO:0020037),0.3045496193768015,0.9066071023477107,0.5946632782719187,1.0,1.0,9/65,13.28%,STC2;PXDN;CYP2S1;SRC;COX15;SDHD;DGCR8;PGRMC1;CYP2U1
prerank,omega peptidase activity (GO:0008242),0.29074193796395,0.9052331223458935,0.61489898989899,1.0,1.0,23/89,18.82%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;USP48;MINDY3;USP47;PAN2;USP13;OTUD7B;USP15;USP4;USP35;COPS5;GGT1;STAMBPL1;STAMBP;USP45;USP53;USP37;PSMD14;USP9X
prerank,voltage-gated cation channel activity (GO:0022843),-0.22441711203043596,-0.9051300862411628,0.6888888888888889,0.885852387958905,1.0,37/97,35.01%,CACNA2D3;KCNB1;KCNMA1;GRIN3A;CACNB2;GRIN2B;KCNH1;KCNB2;KCNH5;GRIN1;CACNG7;KCNC3;CACHD1;OPRM1;CACNA2D4;TPCN2;KCNA2;KCND1;LRRC38;CACNG4;CACNA1B;KCNH2;KCNH8;HCN2;CACNA1D;KCNQ5;HVCN1;KCNQ1;LRRC55;KCNC4;CACNA2D1;CACNA1C;KCNG2;CACNB3;KCNH4;HCN4;CACNG5
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.35292952821494383,0.9040496026385636,0.5799086757990868,1.0,1.0,6/27,11.18%,SLC8B1;SLC12A3;KCNK1;SLC4A11;SLC9A7;SLC9A6
prerank,nuclear receptor coactivator activity (GO:0030374),0.3086551052859943,0.9016024914528512,0.5943517329910141,1.0,1.0,10/52,15.23%,PPARGC1A;SLC30A9;PSMC3IP;MED13;TMF1;NCOA3;NCOA2;BRD8;CCDC62;MED12
prerank,poly(A) binding (GO:0008143),-0.3061052246958681,-0.9002334421127384,0.6284916201117319,0.8916690427292753,1.0,5/21,9.68%,RBPMS;RBMS1;RBMS3;RBMS2;PABPC1
prerank,RNA binding (GO:0003723),0.25195101916315427,0.8996010298138039,0.863,1.0,1.0,347/1321,22.78%,AHNAK;DCN;DHX8;DHX34;PPARGC1A;RPSA;HNRNPC;ASS1;MYBBP1A;CCDC9;CSTF1;CDC42EP4;NUFIP1;FXR2;RBFOX2;HOXB6;DDX27;DND1;QKI;SF3B2;SF3B1;CHD3;BMS1;GIGYF2;PCBP2;RBM8A;DCP1B;SCG3;ADD1;MRPL37;RBM10;MRPL43;UBE2I;CELF1;SRSF4;BUD23;HNRNPA0;NOL8;SECISBP2;PABPC4L;DNM1;CHD2;SAMD4B;SERPINH1;RPUSD2;CAVIN1;SNRPF;HADHB;RBM15B;ZNF326;SON;PABPC4;LRRC59;DXO;ZNF346;HNRNPR;TLR7;CDK13;PUS7;TNS1;KPNA2;TUT1;ZC3H15;FASTKD2;SF3B5;C1D;EIF5B;PPIE;MRPS28;MRPS35;ZCCHC24;N4BP1;LLPH;RARS2;RDX;PRPF3;UTP15;NCOA5;FAM120A;ZFR;ARHGEF1;ALDH18A1;DDX17;CSTF3;CHERP;GNL2;TOP3B;MSI2;DDX46;NOP14;RBM22;ILF2;GOLGB1;SRPK1;RBM5;IGF2BP2;ELAVL2;GPATCH8;SIDT2;DARS1;PCDHGA9;NAF1;RPL35;AATF;WRAP53;AGO1;TCF20;DCAF13;LIN28B;PTCD3;SNU13;SLTM;MRPL41;FLNB;MECP2;CELF2;STAU2;HMGB1;PES1;POP4;EXOSC10;EIF4E;FCF1;CELF4;RPS13;HDAC2;RBM33;RBM27;HNRNPM;PRRC2A;EIF1;EIF1AX;TFB2M;KARS1;RRP12;PTBP3;MRPS15;DQX1;PPHLN1;RBM26;KHDRBS2;ZYX;TPR;POP7;RTRAF;LONP1;DDX43;SRPK2;ATXN2;ILF3;DBR1;MRPL3;LUC7L2;UPF3B;RPF1;UTP14A;CFAP20;HEXIM1;SREK1;TOP1;MAP4;ETF1;SRRM2;ANXA11;DGCR8;CSDE1;UBAP2L;ADAT1;NOP56;PTBP2;RPP14;STRBP;RBM18;LTA4H;NOP58;TEP1;KNOP1;SMG7;TAF15;NSUN5;ZFP36L2;DDX6;NUCKS1;TCERG1;SNRPA1;SFPQ;ALKBH1;NOL7;AIMP1;BAZ2A;NSRP1;MEX3A;TEFM;P4HB;PPIG;FXR1;UBA1;DDX42;CHCHD1;TIAL1;DDX52;RTN4;BZW1;TXN;PUM2;FASTKD1;PPIL4;PYM1;PSMA6;MRPL16;DICER1;REXO4;RBM38;CTNNA1;DHX16;PDCD11;TRA2B;SF1;BICC1;SUGP1;RAN;SEC23IP;CPEB3;ATP5F1A;FLYWCH2;ATP5F1C;DHX57;YWHAG;ZCCHC17;SPOUT1;SRRT;TSNAX;EZR;PSPC1;MRPL40;MRPL22;THOC5;PRKRA;MRM1;YWHAE;DHX40;SYNCRIP;GNL3L;CWC22;RTF1;XPO5;GLRX3;UBFD1;HMGN2;MRPL4;SPTBN1;DARS2;TYW5;ARCN1;ZCCHC7;NOC3L;PTCD1;SARS2;OAS2;NAP1L1;GTPBP1;MRPL2;SRFBP1;STRAP;RPUSD4;PNLDC1;SRSF3;ZNFX1;PEG10;SRBD1;CNOT1;TOE1;G3BP1;HARS2;LSM3;XRCC6;MTREX;GCN1;DHX38;PNISR;DHX9;YBX3;DDX56;SEPSECS;HNRNPD;SUMO1;MBNL2;LARP4;NCBP3;RPP21;NME1;NUDT5;TRMT1L;SAP18;EIF4G2;CS;ZC3H13;JAKMIP1;MKRN1;NUDT21;CCT3;TDRD9;RRS1;GFM1;SRSF12;NKAP;USO1;KCTD12;ADARB1;SRSF11;TIA1;HABP4;TSFM;MRPS7;LRRC47;CCAR2;ZBED4;ENO1;EXOSC7;SRSF10;DDX11;PUM1;SRP68;HSPA9;SECISBP2L;ELAVL1;JUN;FNDC3B;DDX25;YTHDC1;NMD3;THG1L;TFB1M;TRMT1;MRPL11;HELB;SMG6;HNRNPA3;GANAB;PKM;NOL12;PCF11;LSM2;JMJD6;ZC3H18;CPSF2;RBM6
prerank,phospholipid transfer activity (GO:0120014),-0.30530315250083956,-0.89851597718933,0.5833333333333334,0.8903677183361149,1.0,6/21,14.16%,PLTP;PITPNB;TNFAIP8L3;C2CD2L;PRELID2;PRELID3A
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.3794152707364471,-0.8973573171169139,0.5991471215351812,0.887830632655898,1.0,5/10,34.17%,CACNB2;CACNA1B;CACNA1D;CACNA1C;CACNB3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3544170158176034,0.8960257395383424,0.5845648604269293,1.0,1.0,6/22,11.08%,WDR81;TNFAIP3;UIMC1;MINDY2;OTUD7B;TAB2
prerank,CXCR chemokine receptor binding (GO:0045236),-0.35909094478047665,-0.8934090344690038,0.5976744186046512,0.8921973224434405,1.0,2/11,10.15%,CXCL12;YARS1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.35096309677643234,-0.8918248024935866,0.6261467889908257,0.8906140059616131,1.0,5/13,18.66%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,mRNA binding (GO:0003729),0.2599334326113322,0.890761956121673,0.7046413502109705,1.0,1.0,44/249,15.02%,HNRNPC;FXR2;RBFOX2;DND1;QKI;SF3B1;PCBP2;RBM8A;DCP1B;CELF1;SRSF4;HNRNPA0;SECISBP2;PABPC4L;SAMD4B;PABPC4;DXO;HNRNPR;TUT1;PPIE;N4BP1;CSTF3;RBM5;IGF2BP2;ELAVL2;RPL35;CELF2;CELF4;RPS13;HNRNPM;PTBP3;KHDRBS2;TPR;LUC7L2;UPF3B;ETF1;SRRM2;PTBP2;DDX6;NSRP1;FXR1;PUM2;TRA2B;SF1
prerank,methyltransferase activity (GO:0008168),0.30885442334198543,0.8897973276920849,0.5967302452316077,1.0,1.0,9/46,13.64%,MRM2;BUD23;SUV39H1;LRTOMT;GAMT;FTSJ1;ARMT1;MGMT;LCMT1
prerank,ankyrin binding (GO:0030506),0.3656200486146389,0.8884011071459526,0.5711947626841244,1.0,1.0,6/19,20.20%,PTPRC;OBSCN;FLNC;CDH1;SPTBN1;SPTB
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.39129775865981115,0.8883877098794609,0.5950413223140496,1.0,1.0,5/14,13.00%,SLC25A12;SLC1A7;SLC1A6;SLC25A13;SLC25A22
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.3725194463770011,-0.8873073523184104,0.6059225512528473,0.8957640411425359,1.0,5/10,26.19%,ANKRD13A;DNAJB2;LAPTM5;ANKRD13D;DNAJC2
prerank,growth factor receptor binding (GO:0070851),0.2855110987550959,0.8870220088323044,0.6457831325301204,1.0,1.0,19/95,17.10%,FGF7;EFEMP1;GLMN;FGF1;SRC;FER;NCSTN;PTPRJ;FGF18;PLSCR1;ATXN2;IL6ST;SNX2;ERN1;HBEGF;ERBB4;PIBF1;SNX1;ITGA5
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3402913625180885,0.8856151566049504,0.5979680696661829,1.0,1.0,6/29,13.05%,NFATC1;MAPK7;PTPRJ;TNIP1;TPR;DUSP8
prerank,kinase inhibitor activity (GO:0019210),0.3355227914789755,0.8833798798138494,0.6081871345029239,1.0,1.0,12/33,22.32%,PARVA;SPRY4;GMFB;MAPK8IP1;HEXIM1;CDKN1C;SOCS1;WARS1;NCK1;GSKIP;YWHAB;TAOK3
prerank,epidermal growth factor receptor binding (GO:0005154),0.34595728595626696,0.8831105215586985,0.6217851739788199,1.0,1.0,8/25,16.43%,EFEMP1;FER;PLSCR1;ATXN2;SNX2;HBEGF;ERBB4;SNX1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3773239847471902,0.8821667150196045,0.606473594548552,1.0,1.0,2/16,5.83%,ALOXE3;BCO1
prerank,protein phosphatase regulator activity (GO:0019888),-0.23437548280716028,-0.8790978174323221,0.712,0.9085200224410943,1.0,20/53,29.85%,PPP2R2B;PPP4R4;CALM1;IGBP1;PPP4R1;CALM3;PPP2R5A;RCAN2;PPP2R5E;STYXL1;PPP4R2;PTN;PPP2R1A;ARPP19;PPP2R5D;DMPK;PPP2R2D;SHOC2;PPP1R16B;PPP1R15A
prerank,DNA secondary structure binding (GO:0000217),0.3366783136445367,0.876830549882976,0.6332842415316642,1.0,1.0,7/31,12.90%,MSH6;KMT2A;LIN54;MSH2;HMGB1;MEN1;GEN1
prerank,calcium activated cation channel activity (GO:0005227),-0.31489392268931504,-0.876108772353806,0.6586666666666666,0.9104323092195811,1.0,4/17,10.42%,ANO1;KCNMA1;TMEM63B;KCNN2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.3659541657714769,-0.8759444586243214,0.6235565819861432,0.9057081452749116,1.0,4/10,24.90%,ANKRD13A;DNAJB2;LAPTM5;ANKRD13D
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2697710847905254,0.875784955302813,0.6772727272727272,1.0,1.0,22/134,11.57%,SLC35A1;SLC4A3;SLC25A12;SLC35D3;SFXN2;SLC26A9;SLC38A2;SLC1A7;SLC35B2;SLC27A1;SLC22A3;ABCC1;SLC6A13;SLC2A2;SLC4A11;SLC52A1;SLC35D2;SLC7A2;RTBDN;SLC16A1;SLC25A13;SLC3A1
prerank,chloride channel regulator activity (GO:0017081),0.3943653404184083,0.8751772124315407,0.6340640809443507,1.0,1.0,4/14,18.61%,STX1A;VAMP8;SGK1;CHRNA7
prerank,MHC protein binding (GO:0042287),0.36141586823761157,0.8746842404860391,0.604133545310016,1.0,1.0,5/20,16.11%,TAPBP;CD81;ABCB9;ATP5F1A;LAG3
prerank,carboxy-lyase activity (GO:0016831),0.3471211711938146,0.873544302172603,0.6063348416289592,1.0,1.0,3/23,8.58%,PISD;AZIN2;ACOD1
prerank,kinesin binding (GO:0019894),0.3364964306595801,0.8734497089652611,0.6176911544227887,1.0,1.0,13/27,25.44%,RAB29;FAM83D;MAPK8IP1;SPAG9;ARHGEF10;KLC2;PRC1;SPTBN5;CLSTN1;MAPK8IP3;NEK6;TTBK2;KIFAP3
prerank,FAD binding (GO:0071949),0.35105735870088056,0.8732146843620362,0.6056572379367721,1.0,1.0,1/24,0.45%,PRODH
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.28158752324491326,-0.8729545656986838,0.6796407185628742,0.9076575224163747,1.0,7/26,22.90%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1;STYXL1;PTN;ARPP19
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4057037594925958,0.872559404248435,0.6025408348457351,1.0,1.0,6/11,28.08%,STN1;TERF2;RAD50;RPA2;RPA1;TERF2IP
prerank,microtubule binding (GO:0008017),0.25599750519749065,0.871541492483222,0.7305644302449414,1.0,1.0,38/222,14.15%,RGS14;GTSE1;HOOK2;KIF2A;SPEF1;KIF20B;TRPV4;RACGAP1;FAM83D;DNM1;KIF16B;CAPN6;KIF7;SPAST;KIF3C;CKAP5;SGIP1;KIF13A;PAFAH1B1;EML1;FNTA;REEP3;TUBGCP5;S100A9;APC;HDAC6;HOOK3;MAP4;CCDC170;NDE1;CEP290;MAP9;KIF26A;KIF5A;MAPRE2;KIF5B;POLB;FAM161A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3452071055259641,-0.8696036865356048,0.6549295774647887,0.9095610849351964,1.0,4/12,20.15%,PHF8;KDM1A;KDM7A;KDM4D
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.3243446492234957,-0.8681660157116753,0.6078947368421053,0.9077078835733311,1.0,6/14,27.94%,CTSH;NOD1;RACK1;RPS27L;PYCARD;CASP1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.34078225456244343,0.8671729061593108,0.6300309597523219,1.0,1.0,8/24,23.52%,AK5;PPIP5K2;PPIP5K1;AK7;ITPKA;NME1;AK9;NME6
prerank,iron ion binding (GO:0005506),-0.24068875100165274,-0.865564271305473,0.7591836734693878,0.9083839022120609,1.0,12/48,15.19%,EGLN1;PHF8;FTH1;FTL;AOX1;ETHE1;NFU1;FECH;ABCE1;KDM7A;FXN;ISCA2
prerank,R-SMAD binding (GO:0070412),-0.30761448687627524,-0.865283428568817,0.6484375,0.9039843053486327,1.0,2/18,1.65%,SMAD3;SMAD6
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3874734571565996,0.8640368872236642,0.6155115511551155,1.0,1.0,1/14,1.84%,KCNA5
prerank,GABA receptor activity (GO:0016917),0.35395495589891884,0.8630694508550568,0.6206896551724138,1.0,1.0,5/21,12.26%,GABBR2;GABRR2;GABRG2;GABRG1;GABRB3
prerank,methylation-dependent protein binding (GO:0140034),0.29400641371999936,0.8625528252911605,0.6693333333333333,1.0,1.0,24/57,28.34%,MSH6;CHD8;CHD1;MORC3;MSL3;PYGO1;KDM8;SPIN1;KAT8;MTF2;CDYL;MBTD1;CBX2;FMR1;ATRX;BPTF;KDM5A;ING1;TDRD3;RRP8;GLYR1;KDM4A;ING3;ING2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3895531340978997,0.8624430921102945,0.633276740237691,1.0,1.0,6/12,18.95%,CNOT7;PAN2;CNOT8;PNLDC1;CNOT1;TOE1
prerank,potassium ion antiporter activity (GO:0022821),-0.33046483623982675,-0.8609622264169086,0.6395348837209303,0.908099035727013,1.0,5/15,18.66%,SLC24A3;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,mannosyltransferase activity (GO:0000030),-0.29475937503577265,-0.8608535153842407,0.6517150395778364,0.903435286367407,1.0,3/21,4.35%,TMTC2;TMTC1;DPM1
prerank,ligand-gated cation channel activity (GO:0099094),0.28452140784214935,0.8593133739643879,0.657997399219766,1.0,1.0,6/75,6.15%,KCNJ4;KCNJ16;GRIA3;KCNK1;KCNJ13;SHROOM2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2874450737803067,0.8585210916533399,0.6671122994652406,1.0,1.0,20/60,19.37%,PPM1A;CTDSPL;PPM1M;RPAP2;PHLPP1;MTMR6;MTMR3;PDP2;CTDSP1;PTEN;CTDSP2;PPP4C;CTDSPL2;CDC14A;CAMK2G;PPP1CA;PP2D1;PPTC7;ILKAP;PPP2CA
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2840192766348059,0.8583224801508967,0.6831683168316832,1.0,1.0,15/74,15.62%,FAM20C;DGKA;HK2;DGKZ;COASY;ADPGK;GALK1;IDNK;GALK2;GK;HYKK;PIK3C3;NT5C3A;PANK2;FGGY
prerank,phosphatase inhibitor activity (GO:0019212),0.34963925962346104,0.8539011165938819,0.6540880503144654,1.0,1.0,8/20,25.40%,STYX;BOD1L1;ENSA;TESC;LMTK2;PPP1R9B;URI1;PPME1
prerank,four-way junction DNA binding (GO:0000400),0.3609147220281888,0.8521871297505546,0.6504065040650406,1.0,1.0,5/17,12.90%,MSH6;MSH2;HMGB1;MEN1;GEN1
prerank,voltage-gated potassium channel activity (GO:0005249),0.2754020446832323,0.8513038487663144,0.6758104738154613,1.0,1.0,6/80,5.58%,KCNJ4;KCNA5;KCNJ16;KCNS2;KCNK1;KCNJ13
prerank,poly-purine tract binding (GO:0070717),-0.2679898008426388,-0.8503356551552742,0.6886792452830188,0.9200203951912517,1.0,5/27,9.68%,RBPMS;RBMS1;RBMS3;RBMS2;PABPC1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.3122375064353301,-0.8497842325224038,0.6624040920716112,0.9162309354647915,1.0,5/15,12.53%,NDST3;HS3ST1;HS3ST3B1;HS6ST2;HS6ST1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.377686031190647,0.8486958340169228,0.6544502617801047,1.0,1.0,1/14,1.39%,AK5
prerank,voltage-gated calcium channel activity (GO:0005245),-0.2509187632250305,-0.8474472912492653,0.7157190635451505,0.9162127273366778,1.0,15/37,35.01%,CACNA2D3;CACNB2;CACNA1G;CACNG7;CACHD1;OPRM1;CACNA2D4;TPCN2;CACNG4;CACNA1B;CACNA1D;CACNA2D1;CACNA1C;CACNB3;CACNG5
prerank,potassium channel activity (GO:0005267),-0.21028238105999342,-0.8436706699168918,0.8219895287958116,0.9191431097306181,1.0,10/89,10.42%,KCNK2;KCNB1;ABCC9;KCNMA1;KCNH1;KCNT1;GRIK2;KCNB2;KCNH5;KCNN2
prerank,amino acid binding (GO:0016597),-0.2571172463174605,-0.8424453358972186,0.6934984520123839,0.916769226412698,1.0,11/31,20.40%,NOS3;DDAH1;GRIN3A;GRIN2B;GRIN1;GLRA2;NOS1;GCLC;AGXT;CASTOR2;CASTOR1
prerank,phosphatidic acid binding (GO:0070300),0.3539943543135594,0.8408752116326821,0.635048231511254,1.0,1.0,6/19,10.01%,PITPNC1;SESTD1;GRAMD1B;PACSIN2;RAPGEF6;MAPKAP1
prerank,ubiquitin binding (GO:0043130),0.2783700470849533,0.8407858240913507,0.6888604353393086,1.0,1.0,14/73,13.44%,UBE2L6;NUP62;TOM1L1;TSG101;TNFAIP3;OTUB2;N4BP1;NPLOC4;SHARPIN;USP13;NEDD4;BUB3;FAF1;RNF185
prerank,chloride channel inhibitor activity (GO:0019869),0.4024983701490531,0.840442060104552,0.6637168141592921,1.0,1.0,2/10,11.35%,STX1A;VAMP8
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.24523800974548915,0.8377196880585384,0.7931404072883173,1.0,1.0,28/232,11.37%,NEDD4L;PDZRN3;ZNRF2;DTX1;PELI2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LRSAM1;TMEM129;TRIM21;UBR5;RNF24;PIAS2;SIAH1;ZNRF3;CUL3;AMFR;RNF220;SIAH3;DTX4;UBE3D;CBLB;RCHY1;ANAPC11;NEDD4
prerank,single-stranded DNA binding (GO:0003697),-0.20232777094436288,-0.8373904367120467,0.8333333333333334,0.9221204746798829,1.0,39/93,32.05%,RAD51B;SAMHD1;TOP3A;RBMS1;BLM;MCM6;SUB1;PCBP1;SPRTN;SSBP1;POLA1;PMS2;MAPT;APTX;RAD23A;SMC6;DHX36;POLR2D;MCMDC2;ERCC4;CRY2;ERCC5;TWNK;HNRNPA1;NEIL3;WBP11;RAD51;NABP1;CDC45;FUBP1;HMCES;MCM3;CTC1;MCM9;MCM7;HSPD1;MCM5;MCM10;MCM2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.3173111921288527,0.836599265232639,0.6824224519940916,1.0,1.0,5/29,13.33%,PGGHG;ACER3;NEU1;ABHD10;ADPRS
prerank,fibroblast growth factor binding (GO:0017134),0.3386303442452663,0.8353001772767878,0.6666666666666666,1.0,1.0,1/21,0.70%,FGFR1
prerank,cation transmembrane transporter activity (GO:0008324),0.29518568721892186,0.8347517783333516,0.6929238985313751,1.0,1.0,5/48,4.89%,SLC8B1;SFXN2;SLC38A2;SLC29A4;SLC22A3
prerank,RNA cap binding (GO:0000339),0.35558641689132275,0.834013286118426,0.6603119584055459,1.0,1.0,2/16,9.70%,CYFIP2;EIF4E
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.30447412522804235,0.8327517271078678,0.6671408250355618,1.0,1.0,9/34,18.16%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;NDUFS2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.30447412522804235,0.8327517271078678,0.6671408250355618,1.0,1.0,9/34,18.16%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;NDUFS2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.31709346014633694,0.8300533001742915,0.6755555555555556,1.0,1.0,6/31,16.02%,UBE2L6;UBE2E2;UBE2J2;UBE2D3;UBE2D1;UBE2R2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.30458587888367605,-0.828907592479511,0.710455764075067,0.9341433996939486,1.0,8/16,21.17%,SLC13A3;SLC25A30;SLC25A11;SLC38A7;SLC1A1;SLC25A18;SLC1A4;SLC13A5
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2775625946712437,0.827369096883898,0.6997389033942559,1.0,1.0,11/57,15.67%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.27274726351397094,-0.8271204477656986,0.7472826086956522,0.9331387365452796,1.0,5/22,16.71%,ATP6V0A4;ATP2C1;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,cAMP binding (GO:0030552),-0.33112537563764977,-0.8254614918370364,0.7200956937799043,0.9316205143076087,1.0,4/11,12.95%,RAPGEF2;PDE10A;PDE2A;PDE4A
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.34661969588754554,0.8235633895387262,0.6704,1.0,1.0,2/18,9.42%,TNFAIP8;RPS6KA3
prerank,thyroid hormone receptor binding (GO:0046966),0.3126416167160827,0.8231822150596991,0.698340874811463,1.0,1.0,9/28,21.23%,NCOR1;MED13;JMJD1C;NCOA3;GTF2H1;BRD8;MED12;TACC1;MED16
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.23242446436708497,-0.8230241166918508,0.7941176470588235,0.931496417212837,1.0,27/42,38.29%,CCNT2;CNPPD1;CCNT1;CDK5R1;CCNE2;CCNH;CCNJL;KAT2B;CCNY;CCND2;CCNF;CDKN2C;CDKN1B;CCNQ;CCNK;CDKN2D;CCND1;CCNB2;HEXIM2;CCNL1;CDKN2B;CCNL2;CKS2;CDK5R2;CCNI;CCNE1;INCA1
prerank,ribosomal large subunit binding (GO:0043023),-0.32884867585407274,-0.8228759822838573,0.6854460093896714,0.927030069338042,1.0,3/11,12.34%,NPM1;CPEB2;DHX33
prerank,vitamin D receptor binding (GO:0042809),-0.317292577839806,-0.8226692502565752,0.6723300970873787,0.9226698595940113,1.0,7/14,31.09%,MED17;SNW1;MED24;MED14;MED30;TAF11;RXRA
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.30657920074530265,0.8210257391715758,0.6967559943582511,1.0,1.0,10/34,18.95%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;CNOT8;PNLDC1;CNOT1;TOE1
prerank,CoA hydrolase activity (GO:0016289),0.3581215578300554,0.8199466594668287,0.6724683544303798,1.0,1.0,4/16,12.75%,ACOT13;ACOT8;ACOT2;ABCD1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.33923520559788456,-0.8193147445291685,0.6855036855036855,0.924507952263128,1.0,4/11,30.78%,KCNJ8;KCNE4;KCNH2;KCNQ1
prerank,voltage-gated sodium channel activity (GO:0005248),0.32879964865850253,0.8188972560941835,0.7029850746268657,1.0,1.0,3/22,11.00%,SCN10A;CACNA1H;SCN2B
prerank,triglyceride lipase activity (GO:0004806),0.33591924529588324,0.8185826182332722,0.6961832061068702,1.0,1.0,3/20,17.74%,CEL;LIPE;LPL
prerank,flavin adenine dinucleotide binding (GO:0050660),0.2840619255877288,0.8180682854117053,0.7113259668508287,1.0,1.0,5/53,8.51%,PRODH;POR;GFER;GCDH;MICAL3
prerank,small GTPase binding (GO:0031267),0.2446394128248549,0.8160102883253427,0.8030634573304157,1.0,1.0,40/169,19.35%,CAV1;PLCE1;CDC42EP4;RAB29;SGSM2;GCC1;AKAP13;LZTR1;RAPGEF4;RAB3GAP2;RAPGEF6;OCRL;ABCA1;MAPKAP1;GCC2;DOCK7;RIC1;DVL3;DMXL2;RANBP2;EXOC5;EVI5;TRIP11;PDE6D;RAB34;UNC13B;CHM;AP3M1;TBC1D20;RTKN;XPO5;ARHGDIB;RALBP1;ALS2;SIKE1;EHD1;DENND10;ANKFY1;RAF1;YBX3
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.3231154811420822,-0.8157662266134906,0.735224586288416,0.9263056955434776,1.0,3/12,16.15%,TRAF6;BABAM2;TRIM37
prerank,cAMP response element binding (GO:0035497),-0.33563010854431263,-0.8144601784265347,0.7081447963800905,0.9239760275769995,1.0,3/10,11.60%,CREB5;CREB1;ATF2
prerank,ADP binding (GO:0043531),0.3237999734172998,0.8142456941615202,0.6887218045112782,1.0,1.0,10/25,16.57%,MSH6;PRKAG1;COQ8A;MSH2;MIEF1;LONP1;ABCD1;ERN1;ATP5F1A;PGK1
prerank,semaphorin receptor binding (GO:0030215),-0.2625046613489732,-0.8139541744361869,0.7521865889212828,0.9202773646667695,1.0,4/23,5.19%,SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,metalloexopeptidase activity (GO:0008235),0.2865154676980472,0.8137634528226443,0.7179144385026738,1.0,1.0,13/51,16.99%,MMP15;AGBL4;CPE;CPA2;RNPEP;LVRN;LNPEP;XPNPEP3;MMP16;LTA4H;ZMPSTE24;MMP14;AGBL1
prerank,thioesterase binding (GO:0031996),0.36863551049092036,0.8135121428647895,0.6789473684210526,1.0,1.0,7/11,23.35%,ARF6;ADRA2A;TRAF4;TRAF3;TRAF5;HAUS7;RAC1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.30472685573194563,-0.8115218195208898,0.7183462532299741,0.9202188353178501,1.0,12/14,41.97%,QDPR;MTHFR;DHFR;ALDH4A1;PYCR2;AASS;PYCR3;BLVRB;PYCR1;NOXRED1;CRYM;ALDH1L1
prerank,protein heterodimerization activity (GO:0046982),0.2392741477235339,0.8110775449266773,0.8094713656387665,1.0,1.0,31/178,17.31%,TENM2;NPAS3;FXR2;ADD1;BUD23;SMC3;IRAK3;ATP1A2;BHLHE40;MCL1;GABBR2;USF2;PAFAH1B1;PIK3R2;SUPT4H1;ADRA2A;ZHX1;HEXA;PAFAH1B2;SNX2;P4HB;FXR1;EXT1;FZD9;RAN;ADCY8;ERBB2;SNX1;YWHAE;MIGA1;EXT2
prerank,phospholipase inhibitor activity (GO:0004859),-0.3445117576976974,-0.810838242442261,0.7011764705882353,0.9170648342729374,1.0,7/10,36.98%,ANXA2;ANXA1;ANXA9;ANXA5;APOC1;SNCA;SNCB
prerank,ubiquitin protein ligase activity (GO:0061630),0.23782846257152812,0.809864276424897,0.854978354978355,1.0,1.0,27/228,11.37%,NEDD4L;PDZRN3;ZNRF2;DTX1;PELI2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LRSAM1;TMEM129;TRIM21;UBR5;RNF24;SIAH1;ZNRF3;CUL3;AMFR;RNF220;SIAH3;DTX4;UBE3D;CBLB;RCHY1;ANAPC11;NEDD4
prerank,nucleosomal DNA binding (GO:0031492),0.3268220728564636,0.8087570512542546,0.7264,1.0,1.0,3/21,9.90%,HNRNPC;SMARCD2;HDAC2
prerank,N-acetyltransferase activity (GO:0008080),-0.2932030763294403,-0.8080074642379236,0.7272727272727273,0.9178048383983856,1.0,8/19,30.45%,EP300;SMARCE1;SAT1;KAT2B;NAT8L;NAT2;NAT10;NAA50
prerank,galactosyltransferase activity (GO:0008378),0.3769378432727179,0.8064314918962907,0.69,1.0,1.0,2/11,5.84%,A4GALT;A3GALT2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.32957098163564746,-0.806374066446963,0.7084282460136674,0.9161701829785199,1.0,4/11,14.11%,RBX1;UBE2K;UBE4A;UBE4B
prerank,G protein-coupled receptor activity (GO:0004930),0.23814605830176078,0.805490818427368,0.8539445628997868,1.0,1.0,23/239,12.71%,HRH1;LPAR1;ADGRG5;ADGRG2;GPR161;SSTR1;KISS1R;MC5R;MRGPRF;P2RY14;OPN1MW;OPN1MW3;GABBR2;GPR135;TSHR;HCRTR2;GPR101;RORB;ADRA2A;GPR183;LANCL1;GRM1;GPR18
prerank,phosphatase activity (GO:0016791),0.263643793735307,0.803592954216027,0.7596996245306633,1.0,1.0,14/73,15.11%,DUSP12;PLPP2;ACP6;PLPP3;PTPN22;ACP5;ATP1A2;PTPMT1;PTPRJ;OCRL;ARMT1;DUSP8;PTPRO;PLPPR1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.20852232243812108,-0.8030426275751508,0.8625592417061612,0.9174326920813544,1.0,11/70,14.97%,GXYLT2;MGAT4C;MGAT4A;CSGALNACT1;CSGALNACT2;CHPF2;B4GALT1;B3GALT2;LFNG;GCNT1;MFNG
prerank,sulfotransferase activity (GO:0008146),0.2940488228594824,0.8028838259229302,0.7213114754098361,1.0,1.0,5/33,11.13%,UST;SULT1A1;CHST7;CHST2;CHST12
prerank,transcription cis-regulatory region binding (GO:0000976),0.2261462067943813,0.7990635840970443,0.906832298136646,1.0,1.0,62/406,17.11%,RORA;BNC2;GLI1;PBX1;ZBTB20;NPAS3;ETV5;CHD3;SPI1;FOXK1;FOXO3;SOX9;ZBTB8A;GLIS2;HDAC4;SATB1;KLF10;CREB3L1;ZFP3;SP3;ZFP90;CTCF;NCOR1;HOXC10;RREB1;RARA;SUV39H1;LHX6;ISL1;E4F1;FOXK2;AGO1;TBX18;FOXJ1;HMGB1;DBP;TFEB;LONP1;MMP12;EGR1;MZF1;MEN1;NFE2L2;PEG3;ARID4A;SOX4;SFPQ;ZFP57;ERBB4;FOXF1;NR5A1;FOXC2;YAP1;KMT2D;GBX1;PER3;DMTF1;PSPC1;TFE3;MTERF3;E2F1;PPARG
prerank,methylated histone binding (GO:0035064),0.26984701455554966,0.7988478030041701,0.7698412698412699,1.0,1.0,25/62,28.34%,MSH6;CHD8;CHD1;MORC3;MSL3;PYGO1;KDM8;SPIN1;KAT8;MTF2;CDYL;MBTD1;CBX2;FMR1;ATRX;BPTF;KDM5A;TAF1;ING1;TDRD3;RRP8;GLYR1;KDM4A;ING3;ING2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.345752080861913,0.7974456687710156,0.6933115823817292,1.0,1.0,4/14,20.50%,CAPN6;CAPN2;CAPN5;CAPN1
prerank,cholesterol transfer activity (GO:0120020),0.3363887960217812,0.7972096860301034,0.6970684039087948,1.0,1.0,7/16,26.12%,GRAMD1B;ABCA1;STARD5;OSBPL2;STARD4;MTTP;NPC2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.3633794930852017,0.796678038794142,0.706645056726094,1.0,1.0,4/13,16.38%,SOX9;PRKAR2A;GSK3B;EZR
prerank,NF-kappaB binding (GO:0051059),-0.2618951401548465,-0.7956590069103794,0.7890173410404624,0.9258756206513007,1.0,10/24,23.53%,EP300;RNF25;NPM1;HDAC1;BCL10;COMMD7;MTDH;CDK5RAP3;BRMS1;SETD6
prerank,single-stranded RNA binding (GO:0003727),0.28507610803650385,0.7953965705364052,0.7524752475247525,1.0,1.0,18/43,26.43%,TLR7;ZFR;AGO1;EXOSC10;LONP1;ILF3;STRBP;FXR1;DHX9;DDX11;JMJD6;IFIH1;DHX58;AQR;FMR1;AGO2;CNBP;HNRNPU
prerank,RNA methyltransferase activity (GO:0008173),-0.276955855088869,-0.7952679716426343,0.7724867724867724,0.9220394780200912,1.0,8/19,24.74%,TGS1;TRMT13;TRMT9B;TRDMT1;FBL;TYW3;METTL8;TRMT12
prerank,kinase binding (GO:0019900),0.2257025880620601,0.7929550244586772,0.901840490797546,1.0,1.0,49/434,10.37%,CAV1;UTRN;CSPG4;CEACAM1;CNKSR2;SLC12A2;EGFR;CCND3;FAM83A;KCNA5;GYS1;AXIN1;STX1A;MAP3K1;SPRED1;TRPV4;CAV2;RACGAP1;PRKAG1;FOXO3;SLC12A4;PTPN22;FAM83D;HNRNPA0;SRC;DNM1;RAC2;IRAK3;PTPRC;IBTK;TOM1L1;TRADD;ADAM10;TRIM21;SRCIN1;MSH2;FBXO5;PTPRJ;TEX14;IRGM;GSK3B;TOM1L2;TICAM1;DLG3;MAPKAP1;FERMT2;LAT;TAX1BP1;ADRA2A
prerank,tRNA binding (GO:0000049),-0.21989982622842613,-0.7900399141814459,0.8339350180505415,0.9261119023244516,1.0,21/43,39.52%,SSB;EEF1A1;TRNT1;TRMT9B;EIF2AK4;EIF2A;NSUN2;MRPS27;YRDC;XPOT;PUS1;HSD17B10;NAT10;AARS2;ELP1;FARS2;TRMT10C;CTU1;YARS2;NEMF;ELP5
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2359012669799186,0.7893820500300593,0.8270925110132159,1.0,1.0,27/173,13.87%,FOXP2;ZBTB32;KLF12;ZBTB20;FOXK1;FOXO3;FOXP4;SATB1;CREB3L1;HEYL;BHLHE40;ZFP90;CTCF;HIC1;TBX2;MYPOP;E4F1;FOXK2;ZBTB6;TBX18;MZF1;ZBTB49;ZNF148;ERF;PEG3;NFATC4;ZFP57
prerank,MAP kinase kinase activity (GO:0004708),-0.2927036937644514,-0.7892192247174098,0.7536945812807881,0.9228940506468629,1.0,8/15,28.14%,MAP2K2;LRRK2;MAP2K3;MAPKAPK3;MAP2K6;MAP2K1;MAP2K4;MAP2K5
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3382124078287347,0.7871640149638287,0.7092651757188498,1.0,1.0,4/17,12.75%,ACOT13;ACOT8;ACOT2;ABCD1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3633822091287476,0.7867175827982382,0.7068965517241379,1.0,1.0,1/12,2.58%,CDH5
prerank,GABA-A receptor activity (GO:0004890),0.33754765348105553,0.7863870909259801,0.71869918699187,1.0,1.0,4/18,12.26%,GABRR2;GABRG2;GABRG1;GABRB3
prerank,transferrin receptor binding (GO:1990459),0.36286163521669135,0.7862478571173022,0.7160068846815835,1.0,1.0,4/10,21.30%,SNX2;CD81;SNX1;RGMA
prerank,potassium ion leak channel activity (GO:0022841),0.3418726099347805,0.7860054633015348,0.709731543624161,1.0,1.0,4/15,13.89%,KCNK1;KCNK5;KCNK10;KCNK4
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3173803397002465,-0.785518944853243,0.7702020202020202,0.9242453232252985,1.0,3/11,17.76%,SLC17A5;SLC2A10;SLC2A9
prerank,titin binding (GO:0031432),0.35095748293748563,0.7824065119294223,0.7128205128205128,1.0,1.0,2/13,8.79%,CAMK2D;OBSCN
prerank,acetylation-dependent protein binding (GO:0140033),0.3160220813776765,0.782307941603156,0.7216981132075472,1.0,1.0,5/20,17.55%,MLLT3;KMT2A;BAZ2A;BRD3;PSME4
prerank,lysine-acetylated histone binding (GO:0070577),0.3160220813776765,0.782307941603156,0.7216981132075472,1.0,1.0,5/20,17.55%,MLLT3;KMT2A;BAZ2A;BRD3;PSME4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.2188395636919079,-0.7808729679372844,0.8642857142857143,0.9271000410964949,1.0,5/44,8.59%,MECOM;SETD5;SETD1A;PRDM16;SMYD2
prerank,nuclear import signal receptor activity (GO:0061608),0.34133453879433334,0.7799710132850127,0.7346600331674958,1.0,1.0,2/15,5.83%,KPNA7;KPNA2
prerank,NADPH binding (GO:0070402),-0.30333604876923104,-0.7799277987018306,0.7528604118993135,0.9242049870215664,1.0,7/13,34.08%,QDPR;DHFR;MTRR;CRYZ;DUS2;LBR;NDOR1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.34941057615710097,0.7791363544754921,0.7252931323283082,1.0,1.0,6/13,30.37%,GEN1;DICER1;SLX4;DNASE1L1;ENDOV;DNA2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3554210165786509,0.7756209652859433,0.7171717171717171,1.0,1.0,3/11,13.82%,NTHL1;APEX2;ALKBH1
prerank,adenylyltransferase activity (GO:0070566),0.3174907988053034,0.7750177825302056,0.7609046849757674,1.0,1.0,6/21,18.56%,TUT1;COASY;NMNAT3;KARS1;OAS2;PAPOLG
prerank,1-phosphatidylinositol binding (GO:0005545),0.3423748396340387,0.7743913054871038,0.7512116316639742,1.0,1.0,3/15,6.96%,SESTD1;ZFYVE16;SNX10
prerank,motor activity (GO:0003774),0.2604806761585514,0.7740202966676126,0.783289817232376,1.0,1.0,10/60,13.61%,KIF2A;KIF20B;SMC3;KIF16B;KIF7;KIF3C;KIF13A;KIF26A;KIF5A;KIF5B
prerank,ubiquitin-protein transferase activity (GO:0004842),0.22093774757629342,0.773900095008384,0.9044193216855088,1.0,1.0,79/346,22.15%,NEDD4L;PDZRN3;UBE2L6;ZNRF2;DTX1;PELI2;UBE2E2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LMO7;LRSAM1;TMEM129;TNFAIP3;TRIM21;UBR5;CHFR;RNF24;SIAH1;ZNRF3;CUL3;FBXO3;AMFR;RNF220;SIAH3;DTX4;UBE3D;CBLB;SHARPIN;OBI1;RCHY1;ANAPC11;NEDD4;KLHL21;FBXL5;TTC3;FBXO11;RFWD3;RNF185;FBXO21;ANKRD39;UBE2J2;UBE2D3;UBE2D1;ANAPC4;WWP2;FBXW8;TRIM5;DDB2;FANCL;UBE2R2;LTN1;FBXL3;ITCH;CUL4B;RNF7;VPS11;CDC23;RNF180;RNFT2;GID4;SEL1L;UBE2W;PRKN;MKRN1;RNF146;RNF14;MUL1;TRAF3;TRAF5;TRAF7;ZNRF1;AKTIP;RNF157;CUL5;MIB2;FBXW11
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.30456634583993153,-0.7707873400941586,0.7636363636363637,0.9338639960101186,1.0,2/12,3.84%,PIK3R1;FRS2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2893967609425931,0.769325777983117,0.7637130801687764,1.0,1.0,9/33,18.95%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;CNOT8;PNLDC1;TOE1
prerank,phosphatidate phosphatase activity (GO:0008195),0.34148755167251865,0.7691066507147315,0.7309562398703403,1.0,1.0,2/13,4.15%,PLPP2;PLPP3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2912686852803128,0.7678318422953291,0.7707736389684814,1.0,1.0,14/32,24.96%,EGLN3;TET1;P4HTM;KDM8;ALKBH1;PHYH;KDM4B;HSPBAP1;TYW5;ALKBH4;ALKBH2;KDM2A;TMLHE;ALKBH3
prerank,solute:sodium symporter activity (GO:0015370),-0.24188864975905183,-0.7676171392592148,0.8272727272727273,0.9341122292244661,1.0,2/27,4.87%,SLC4A10;SLC5A6
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.3216119643777805,0.7653207234194146,0.7610759493670886,1.0,1.0,8/19,22.55%,GRID1;GABRG2;GABRG1;GRIK1;GRIK5;GABRA3;GRIK3;GRID2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3214890815935596,0.7640081802332299,0.7434640522875817,1.0,1.0,1/17,1.39%,AK5
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.28186718197103394,0.7639788184702002,0.7824267782426778,1.0,1.0,8/38,11.71%,PHLDA3;SESTD1;LANCL2;KIF16B;SH3PXD2B;PLEKHA4;OBSCN;ZFYVE26
prerank,N-acyltransferase activity (GO:0016410),0.2853015085037937,0.7635259732681141,0.7696793002915452,1.0,1.0,7/32,15.84%,CERS6;PLAAT5;SAT2;SIRT7;NAT14;NAA10;NMT1
prerank,acetyltransferase activity (GO:0016407),0.2863363343712142,0.7634965893382639,0.7561327561327561,0.9980723473561974,1.0,9/31,14.96%,KAT6B;ACAT1;SAT2;PAFAH1B2;NAT14;PAFAH2;CREBBP;KAT8;NAA10
prerank,GTPase binding (GO:0051020),0.22668940687812392,0.7626202911499143,0.8859934853420195,0.9966248032153202,1.0,55/194,22.62%,CAV1;PLCE1;CDC42EP4;RAB29;SGSM2;GCC1;AKAP13;LZTR1;RAPGEF4;RAB3GAP2;RAPGEF6;OCRL;ABCA1;MAPKAP1;GCC2;DOCK7;RIC1;DVL3;DMXL2;RANBP2;EXOC5;EVI5;TRIP11;RRAGB;AIMP1;PDE6D;RAB34;UNC13B;CHM;AP3M1;TBC1D20;RTKN;BNIP3;XPO5;ARHGDIB;RALBP1;ALS2;SPTBN1;LCP1;SIKE1;EHD1;DENND10;ANKFY1;RAF1;YBX3;PPP6R1;STOML2;GOLGA4;ENO1;ATG14;TSC2;ERC1;RAB3GAP1;IQGAP1;LSM2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.25543255265698284,-0.7623165893719042,0.8238341968911918,0.9376939387474328,1.0,13/21,50.77%,GRIK2;P2RX7;P2RX4;CHRNA4;CHRNB2;P2RX5;CHRNB1;P2RX6;CHRNA9;CHRNA5;CHRNA3;P2RX1;CHRNB4
prerank,endoribonuclease activity (GO:0004521),0.28485866487225325,0.7621365503934254,0.7897058823529411,0.9945777744547716,1.0,6/32,16.32%,PIWIL2;AGO1;EXOG;ERN1;DICER1;TSNAX
prerank,SH3 domain binding (GO:0017124),0.25740106949371405,0.7617913291527257,0.8073878627968337,0.9923395965552196,1.0,16/62,21.24%,WIPF1;PTPN22;CNTNAP1;SGIP1;PLSCR1;CBLB;SH3BP2;SOCS7;LANCL1;RUFY2;REPS1;ESPN;PTPN12;AFAP1;PRKN;RAD9A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.2792053230625856,-0.7614533767386703,0.783375314861461,0.9303443063895462,1.0,4/16,16.71%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.2792053230625856,-0.7614533767386703,0.783375314861461,0.9303443063895462,1.0,4/16,16.71%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,lipase activity (GO:0016298),0.274589053116805,0.7614465006617585,0.7900403768506057,0.9899857530109656,1.0,9/43,19.50%,CEL;DDHD1;ABHD12;LIPE;PNPLA8;SEC23IP;LPL;PITPNM3;FAAH
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3471997510335958,0.7591692415304885,0.7406143344709898,0.9907539713743069,1.0,5/11,25.77%,FBXO11;PRMT6;PRMT9;PRMT8;PRMT3
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.315363328453248,-0.7588927641808295,0.7966101694915254,0.9257420454435431,1.0,7/10,43.59%,DUSP10;DUSP7;DUSP1;DUSP4;DUSP5;DUSP16;DUSP2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.315363328453248,-0.7588927641808295,0.7966101694915254,0.9257420454435431,1.0,7/10,43.59%,DUSP10;DUSP7;DUSP1;DUSP4;DUSP5;DUSP16;DUSP2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3085423136857699,-0.7585564319192205,0.7704918032786885,0.9221459870408241,1.0,2/11,7.55%,KSR1;MAP2K2
prerank,nucleotidyltransferase activity (GO:0016779),-0.2624945336732702,-0.7583473022721157,0.8240223463687151,0.9183112687551311,1.0,6/19,19.73%,PAPSS1;TENT2;TUT7;MTPAP;YRDC;CGAS
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2608686855185285,0.7582573909229626,0.797634691195795,0.9894187107925966,1.0,9/54,11.27%,ACER3;HDAC4;NIT2;NADSYN1;NIT1;DARS1;SIRT7;HDAC2;HDAC6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.3165238871533404,-0.75633152994261,0.7740492170022372,0.9169724336599521,1.0,7/10,38.29%,KAT2B;CDKN2C;CDKN1B;CDKN2D;HEXIM2;CDKN2B;INCA1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3487463589091968,0.7549176809098895,0.7470288624787776,0.9916455477254872,1.0,4/12,18.56%,TUT1;TENT5C;TENT5D;PAPOLG
prerank,lipase activator activity (GO:0060229),0.35654031269638276,0.7545355845790861,0.75736568457539,0.9894285672667948,1.0,3/10,18.55%,SRC;BTK;PDPK1
prerank,neuropeptide binding (GO:0042923),0.31435846667972955,0.7520816768581314,0.7440381558028617,0.9903325427686994,1.0,1/18,2.40%,SSTR1
prerank,potassium:proton antiporter activity (GO:0015386),-0.3230236148473297,-0.7472316964094745,0.7763440860215054,0.9251163474160939,1.0,4/10,18.66%,SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,tRNA methyltransferase activity (GO:0008175),0.3147285791677559,0.7464501941885026,0.7478849407783418,0.9962988639008299,1.0,6/16,18.39%,TARBP1;FTSJ1;TRMT5;THUMPD3;METTL2B;METTL2A
prerank,MHC class II protein complex binding (GO:0023026),0.3492428052347625,0.7453461178244978,0.7538726333907056,0.9951624837685829,1.0,5/11,22.51%,ANXA11;CD81;YWHAE;MS4A1;PKM
prerank,calcium-activated potassium channel activity (GO:0015269),-0.31252627295964325,-0.7447215462274707,0.8072289156626506,0.924371644633336,1.0,7/11,37.41%,KCNMA1;KCNN2;KCNN3;PKD2L1;KCNN4;KCNN1;KCNMB2
prerank,DNA polymerase binding (GO:0070182),0.3168092206686417,0.7428506423415808,0.7683333333333333,0.9961015454157222,1.0,4/18,14.12%,HMGB1;LONP1;CDK2AP1;POLG2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.25177437107273964,-0.7412673425849409,0.819371727748691,0.9245383714804225,1.0,7/22,18.05%,RBMS3;CPEB2;ZC3H12A;CPSF1;ZFP36;DHX36;CPEB1
prerank,glutamate receptor activity (GO:0008066),-0.25942264911331697,-0.7393013382853715,0.824,0.9230126423488896,1.0,3/19,7.84%,GRM3;GRIA2;GRIK2
prerank,water transmembrane transporter activity (GO:0005372),0.35264682767893785,0.7384053603254404,0.7889273356401384,0.9997357135866446,1.0,2/11,12.99%,SLC4A11;AQP1
prerank,chloride channel activity (GO:0005254),0.25247503698377816,0.7365892510536176,0.8459563543003851,0.9996652211119347,1.0,9/59,12.26%,SLC26A9;ANO6;CLCN2;CLCN1;GABRR2;GABRG2;BEST1;GABRG1;GABRB3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2949297995773259,0.7349799507415347,0.784375,0.9990384402628986,1.0,4/24,8.79%,SESTD1;LANCL2;CERT1;OBSCN
prerank,single-stranded DNA helicase activity (GO:0017116),-0.25625891430488723,-0.7338027732841389,0.8328611898016998,0.9257212529099338,1.0,12/19,37.80%,MCM6;POLQ;HELQ;RFC2;RAD51;RFC4;MCM7;MCM5;MCM2;RFC5;CHTF18;PIF1
prerank,ubiquitin-specific protease binding (GO:1990381),0.3058036235796567,0.7336432457546735,0.7699386503067485,0.9980847041762966,1.0,8/19,22.71%,SELENOS;AMFR;PTEN;LCOR;SUMO1;PRKN;DERL1;RHBDD2
prerank,symporter activity (GO:0015293),-0.3049801053627094,-0.7319727094183859,0.8159090909090909,0.9240603754467478,1.0,2/10,13.12%,SLC5A6;MFSD2A
prerank,Hsp70 protein binding (GO:0030544),-0.22242495299023773,-0.7302444618905443,0.8609271523178808,0.9220762673106488,1.0,18/31,39.87%,DNAJB2;DNAJA1;GPR37;RPS3;HDAC8;NOD2;DNAJC2;TSC1;DNAJB1;MVD;PPID;FICD;PACRG;SNCA;RNF207;PPEF2;DNAJB14;CYP2E1
prerank,P-type ion transporter activity (GO:0015662),-0.29001034082006744,-0.7297512307587398,0.8359375,0.9187125617635735,1.0,3/12,13.55%,ATP7A;ATP2C1;ATP2B3
prerank,ferrous iron binding (GO:0008198),-0.2411232769242589,-0.7254423096956119,0.86,0.9197667073784068,1.0,5/21,14.08%,EGLN1;FTH1;FTL;FECH;FXN
prerank,O-methyltransferase activity (GO:0008171),-0.2986533383263701,-0.7246146730211482,0.8133971291866029,0.9168453153268552,1.0,2/10,11.75%,COMT;COQ3
prerank,sterol transfer activity (GO:0120015),0.30661787498869897,0.7233896659423142,0.7809364548494984,1.0,1.0,4/17,16.51%,GRAMD1B;ABCA1;STARD5;OSBPL2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.2768171078455016,0.7205055145761438,0.8187221396731055,1.0,1.0,9/28,22.55%,GRID1;GABRG2;GABRG1;GRIK1;GRIK5;CHRNA7;GABRA3;GRIK3;GRID2
prerank,3'-5' exonuclease activity (GO:0008408),0.25821762636379997,0.7196457318587763,0.8450331125827815,1.0,1.0,14/45,21.48%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;REXO4;REV3L;CNOT8;PNLDC1;TOE1;MRE11;RAD9A;EXOSC7
prerank,aspartic-type endopeptidase activity (GO:0004190),0.3288390712994063,0.7190498949256031,0.788659793814433,1.0,1.0,5/12,29.13%,BACE2;BACE1;HM13;SPPL3;CTSE
prerank,nucleotidase activity (GO:0008252),-0.26565379353373964,-0.7175260904629599,0.8316831683168316,0.9209459750645803,1.0,5/15,18.92%,BPNT2;NT5C3B;NT5DC1;NT5C;NT5C1A
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.21908517771440938,-0.7160957260428171,0.9174603174603174,0.9187518026240175,1.0,13/35,25.19%,TRMT13;QRSL1;TRIT1;TRMT9B;TRDMT1;PUS10;DUS3L;DUS1L;MRPL58;GATC;TYW3;TRMT12;TRPT1
prerank,microtubule plus-end binding (GO:0051010),-0.24355530210034274,-0.7159504103094243,0.9083333333333333,0.9150142536387421,1.0,2/20,3.37%,CLIP1;DST
prerank,phosphoric ester hydrolase activity (GO:0042578),0.24756658405073062,0.715520665252862,0.8509485094850948,1.0,1.0,10/49,17.05%,DUSP12;ACP6;PTPN22;ATP1A2;PTPRJ;ARMT1;DUSP8;PTPRO;GDPD3;PPP1CA
prerank,microtubule minus-end binding (GO:0051011),-0.27404014009675626,-0.7136895579360304,0.8392434988179669,0.9135880328519705,1.0,3/13,10.51%,TUBGCP4;CAMSAP1;MACF1
prerank,rRNA binding (GO:0019843),-0.1998333417341602,-0.7134889008250093,0.9375,0.9099814966721641,1.0,17/42,27.69%,RPLP0;MRPS6;RPS3;RPL23;NGRN;MRPL18;MRPS27;MRPS11;PPAN;RPL5;MTERF4;RPS9;RPS14;ERAL1;FASTKD5;RPF2;RPL11
prerank,cysteine-type peptidase activity (GO:0008234),0.230549026445792,0.7133986502817521,0.8894472361809045,1.0,1.0,12/73,14.70%,USP50;TINAGL1;USP8;USP48;BLMH;USP47;USP13;OTUD7B;USP15;CAPN2;ATG4C;USP35
prerank,nuclear localization sequence binding (GO:0008139),0.29476035098785014,0.7102229419086342,0.7962962962962963,1.0,1.0,3/18,13.02%,KPNA7;KPNA2;NUP153
prerank,5'-3' exonuclease activity (GO:0008409),0.31595833764352405,0.7086188697731084,0.7914529914529914,1.0,1.0,3/14,19.02%,DXO;EXOG;MRE11
prerank,MHC class I protein binding (GO:0042288),0.3227459476568105,0.7080316554489621,0.8101933216168717,1.0,1.0,4/13,21.89%,TAPBP;ABCB9;ATP5F1A;DERL1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.30504875116319785,0.7015022749939023,0.8316993464052288,1.0,1.0,4/15,20.37%,PI4K2B;PIK3C3;PI4K2A;PIK3C2B
prerank,estrogen receptor binding (GO:0030331),0.2635921756861812,0.696015115775695,0.849112426035503,1.0,1.0,9/32,20.00%,TAF10;NRIP1;ISL1;DCAF13;STRN;LCOR;CCDC62;CNOT1;TACC1
prerank,deoxyribonuclease activity (GO:0004536),-0.2598056033910886,-0.6949787791843964,0.8604060913705583,0.9251331288801797,1.0,5/14,21.93%,RPS3;ZRANB3;ERCC4;APLF;ERCC5
prerank,hexosyltransferase activity (GO:0016758),0.21820796039126916,0.6945482966486441,0.9206349206349206,1.0,1.0,12/101,10.86%,OGT;B3GALT1;A4GALT;GCNT4;B4GAT1;B3GLCT;PIGB;GCNT2;DPY19L4;POFUT1;ALG9;HEXA
prerank,acylglycerol lipase activity (GO:0047372),0.31947639263300265,0.6920094334994861,0.7886178861788617,1.0,1.0,3/11,19.50%,ABHD12;LIPE;FAAH
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.30443244600703157,0.6903507544135882,0.8316831683168316,1.0,1.0,15/15,69.59%,PLA2G4A;PLA2G4C;PLA2G4E;PLA2G1B;PLA2G4D;PLA2G2E;PLA2G2F;PLA2G12A;PLA2G10;PLA2G2D;PLA2G2C;PLA2G3;PLA2G5;PLA2G4B;PLA2G4F
prerank,protease binding (GO:0002020),0.21621006324624964,0.6886497285415779,0.9144893111638955,1.0,1.0,15/99,13.02%,FAP;SLC2A13;FN1;TNFAIP3;SELENOS;COL3A1;NLRC4;DPP4;AMFR;ATP9A;GSK3B;DVL3;COL1A1;PTEN;ADAMTSL4
prerank,SUMO binding (GO:0032183),0.3070178240354861,0.6863754682438462,0.8183361629881154,1.0,1.0,1/13,2.63%,TDG
prerank,ligand-gated calcium channel activity (GO:0099604),0.2817899081242862,0.6854337868601859,0.8519736842105263,1.0,1.0,1/19,1.41%,ITPR3
prerank,guanyl ribonucleotide binding (GO:0032561),0.20304774243777718,0.6823349284131806,0.9615384615384616,1.0,1.0,22/196,9.35%,RAP1A;RAB8B;RAB29;MRAS;RASEF;BMS1;LANCL2;RAC2;ARL11;PIP4K2B;CNGB1;ARHGEF5;NRAS;KRAS;CNGA4;RHOJ;TUBG1;GNL2;ATL2;ARF6;MIEF1;ARL4A
prerank,endodeoxyribonuclease activity (GO:0004520),-0.23397636417239842,-0.6807603644903986,0.9093406593406593,0.934557519349703,1.0,6/20,21.93%,RPS3;ZRANB3;ERCC4;DCLRE1C;APLF;ERCC5
prerank,nuclease activity (GO:0004518),0.23793397833937152,0.6807133712545553,0.8932432432432432,1.0,1.0,18/52,26.48%,NTHL1;N4BP1;DIS3L2;DFFB;PLSCR1;EXOG;REXO1;REXO4;RNASE3;MRE11;NME1;N4BP2;RNASE1;RNASEH1;DNASE1L1;OGG1;AEN;ANG
prerank,retinoid X receptor binding (GO:0046965),0.3053550188358913,0.6725690180050411,0.8504347826086956,1.0,1.0,4/11,20.00%,NRIP1;RARG;PPARG;TACC1
prerank,glucuronosyltransferase activity (GO:0015020),0.2733989706694029,0.6718759268999878,0.8624,1.0,1.0,5/19,25.42%,B4GAT1;EXT1;EXT2;B3GAT2;CHPF
prerank,ATPase regulator activity (GO:0060590),0.24570300948143792,0.6686051252852739,0.9021897810218978,1.0,1.0,10/38,19.36%,HSPH1;SIL1;BAG3;ATP1B3;AHSA1;BAG2;DNAJC24;DNAJB4;DNAJC19;GRPEL2
prerank,GTP binding (GO:0005525),0.20094029021417784,0.6683832427699296,0.9699331848552338,1.0,1.0,17/172,7.65%,RAP1A;RAB29;MRAS;RASEF;BMS1;LANCL2;RAC2;ARL11;PIP4K2B;ARHGEF5;NRAS;KRAS;RHOJ;TUBG1;GNL2;ATL2;ARF6
prerank,endonuclease activity (GO:0004519),0.23208881177261168,0.6651492776553443,0.9038461538461539,1.0,1.0,8/49,16.32%,PIWIL2;NTHL1;AGO1;EXOG;ERN1;DICER1;REXO4;TSNAX
prerank,glucose transmembrane transporter activity (GO:0005355),0.2828336586386084,0.6637529803874151,0.867579908675799,1.0,1.0,3/17,12.77%,SLC2A2;SLC5A3;SLC5A11
prerank,nuclear receptor binding (GO:0016922),0.2073635178441721,0.6637121511014263,0.9612676056338029,1.0,1.0,28/111,21.70%,PPARGC1A;TAF10;NRIP1;NCOR1;ISL1;DCAF13;MED13;TMF1;STRN;NCOR2;JMJD1C;NCOA3;NCOA2;GTF2H1;BAZ2A;BRD8;LCOR;CCDC62;MED12;CNOT1;TACC2;TACC1;STAT5B;RNF14;MED16;DAXX;ARID1A;TCF7L2
prerank,phosphatidylglycerol binding (GO:1901611),0.2857946015373981,0.6577858460447112,0.8585858585858586,1.0,1.0,3/13,13.87%,PITPNC1;MME;GSDMD
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.24267170845457414,0.6562619109388366,0.8964028776978418,1.0,1.0,10/34,22.65%,SUV39H1;MEN1;ATPSCKMT;SETD2;CAMKMT;ETFBKMT;KMT5A;SETDB1;VCPKMT;EEF2KMT
prerank,hexose transmembrane transporter activity (GO:0015149),0.30377207656726457,0.654885656470242,0.8842443729903537,1.0,1.0,3/12,19.78%,SLC2A2;SLC5A3;MFSD4A
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.252469655888434,0.6540965100478332,0.878419452887538,1.0,1.0,6/29,14.92%,SLC25A12;SLC26A9;SLC1A6;SLC25A13;SLC25A22;SLC46A1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.23533086730203545,0.6534856267806068,0.8948106591865358,1.0,1.0,11/40,18.81%,TARBP1;SUV39H1;LRTOMT;GAMT;METTL9;ARMT1;LCMT1;THUMPD3;METTL2B;METTL2A;ICMT
prerank,double-stranded RNA binding (GO:0003725),0.21371532993953854,0.6512792557488534,0.9530026109660574,1.0,1.0,24/70,25.00%,ZNF346;TLR7;ZFR;ILF2;SIDT2;AGO1;STAU2;ILF3;DGCR8;STRBP;FXR1;DICER1;PRKRA;OAS2;DHX9;ADARB1;ELAVL1;IFIH1;ACTN1;DHX58;TUBA1B;PRKRIP1;DHX30;FMR1
prerank,NAD+ binding (GO:0070403),0.29120278845474473,0.6498900238358007,0.843859649122807,1.0,1.0,5/12,22.93%,SIRT3;HPGD;GLUD1;SIRT2;UXS1
prerank,damaged DNA binding (GO:0003684),0.23331754399997187,0.6493963568483724,0.9197183098591549,1.0,1.0,8/44,17.29%,TDG;NTHL1;NBN;HMGB1;ERCC1;CREBBP;DDB2;CUL4B
prerank,U6 snRNA binding (GO:0017070),0.28710393929654193,0.6489217170680873,0.8454861111111112,1.0,1.0,2/14,7.90%,TUT1;RBM22
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.1614171543135275,-0.6478854595110622,0.9880952380952381,0.9577114730456594,1.0,13/85,15.89%,ENPP2;NDST3;LYPLA1;NOTUM;ASPG;ABHD5;ABHD3;PNPLA6;ABHD2;LYPLAL1;LIPA;PGLS;CA2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.3061548771111129,0.6471407610774779,0.8681506849315068,1.0,1.0,1/10,5.54%,SLC6A13
prerank,exonuclease activity (GO:0004527),0.23258689275490516,0.6428379977647183,0.9445214979195562,1.0,1.0,10/46,14.70%,EXOSC5;DXO;REXO2;EXOSC10;CNOT7;EXOG;APEX2;REXO1;REXO4;REV3L
prerank,transmitter-gated ion channel activity (GO:0022824),0.24861843499099964,0.6371570922266693,0.9018126888217523,1.0,1.0,11/29,23.76%,GRID1;GABRG2;GABRG1;GABRB3;GLRA3;GRIK1;GRIK5;GABRA3;GRIK3;GRID2;GRIA4
prerank,protein kinase regulator activity (GO:0019887),0.2041257547429271,0.6369221309885473,0.9596678529062871,1.0,1.0,12/95,12.13%,PARVA;CCND3;PRKAG1;SPRY4;CCNG1;GMFB;PRKAR2A;CCNJ;MAPK8IP1;APC;HEXIM1;FAF1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.27749619075369847,0.6358860857575878,0.8670120898100173,1.0,1.0,3/15,20.72%,KMT2A;KMT2D;ASH2L
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.25798682608729184,0.6319063996085605,0.9052969502407705,1.0,1.0,3/22,13.05%,DUSP12;MTMR3;DUSP8
prerank,retinoic acid receptor binding (GO:0042974),0.2610082773227779,0.6307332658074412,0.8769968051118211,1.0,1.0,5/17,20.00%,NRIP1;RARG;PPARG;CNOT1;TACC1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2884404309359633,0.6275251432701971,0.8962585034013606,1.0,1.0,4/11,19.07%,SLC35B2;SLC17A9;SLC19A1;SLC25A17
prerank,muscle alpha-actinin binding (GO:0051371),0.269059469618979,0.6274949635415547,0.8982229402261712,1.0,1.0,1/15,2.25%,PDLIM4
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.24812746934498545,-0.6249100599276124,0.8979591836734694,0.9695866622107755,1.0,1/12,1.28%,ENTPD1
prerank,5'-nucleotidase activity (GO:0008253),-0.24000804778604967,-0.6246951093605153,0.9266503667481663,0.9657299914668731,1.0,4/13,18.92%,NT5C3B;NT5DC1;NT5C;NT5C1A
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.2850344231291474,0.6220477066539362,0.8907563025210085,1.0,1.0,3/12,12.26%,GABRG2;GABRG1;GABRB3
prerank,pentosyltransferase activity (GO:0016763),0.22951963484811538,0.6205328797722715,0.9267935578330894,1.0,1.0,6/36,14.68%,UPP2;SIRT3;PPAT;PARP11;PARP6;PARP8
prerank,ligand-gated ion channel activity (GO:0015276),0.23390099269678988,0.616528401559832,0.9150521609538003,1.0,1.0,4/30,9.86%,GRIA3;CNGB1;GRID1;GRIA1
prerank,ligand-gated channel activity (GO:0022834),0.23580158317474018,0.6161077466947538,0.9136904761904762,1.0,1.0,4/29,9.86%,GRIA3;CNGB1;GRID1;GRIA1
prerank,translation initiation factor activity (GO:0003743),0.22351448335420543,0.6143893332555573,0.9283707865168539,1.0,1.0,6/36,14.90%,EIF2B3;EIF5B;EIF4E;EIF1;EIF2B4;COPS5
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.23474972686297382,0.6125172265424433,0.9311377245508982,1.0,1.0,10/28,25.78%,POP4;POP7;DBR1;RPP14;DICER1;RPP21;RPP30;RNASEH1;PRORP;AGO2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.27406818541340294,0.6087283900114884,0.9035532994923858,1.0,1.0,4/12,19.07%,SLC35B2;SLC17A9;SLC19A1;SLC25A17
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.2769744094604442,0.5978771184051969,0.9195804195804196,1.0,1.0,6/11,28.27%,NAA10;NAA40;NAA60;NAA30;NAA20;NAA80
prerank,aspartic-type peptidase activity (GO:0070001),0.2836739056089273,0.5967382818523508,0.8797127468581688,1.0,1.0,2/10,16.37%,BACE2;BACE1
prerank,leucine zipper domain binding (GO:0043522),-0.24993170657099856,-0.5953786864798947,0.9315403422982885,0.9779103975475664,1.0,3/10,19.54%,PAWR;ATF4;DAPK3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.18726426921148592,-0.5813508037526124,0.9821958456973294,0.980601597939494,1.0,9/25,29.27%,ART3;ZC3HAV1;PARP2;PARP10;PARP1;TNKS2;PARP3;PARP16;SIRT6
prerank,histone deacetylase binding (GO:0042826),0.18879515388064583,0.578084979166167,0.9915356711003628,1.0,1.0,24/88,22.93%,SPI1;HDAC4;DACT1;KPNA2;HIC1;NCOR1;HDAC2;NCOR2;HDAC6;SFPQ;CAMTA2;LCOR;YWHAE;GMNN;MTA3;HDAC3;RBBP4;PRKN;NUDT21;MAPK8;RAD9A;BRMS1L;YWHAB;SIRT2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.23615167251250435,0.5779947883026554,0.9559055118110236,1.0,1.0,8/21,24.44%,POLI;POLB;REV3L;POLE;CHRAC1;POLE2;PRIMPOL;REV1
prerank,DNA polymerase activity (GO:0034061),0.23151662055605177,0.5715854390812004,0.9525316455696202,1.0,1.0,8/22,24.44%,POLI;POLB;REV3L;POLE;CHRAC1;POLE2;PRIMPOL;REV1
prerank,snRNA binding (GO:0017069),0.20472548749237057,0.5690911360587266,0.9655172413793104,1.0,1.0,6/42,13.66%,RNPC3;TUT1;RBM22;SNU13;HEXIM1;SNRPA1
prerank,histone methyltransferase binding (GO:1990226),-0.2316976724842687,-0.5620389607276051,0.9438444924406048,0.9842671480256142,1.0,1/11,4.33%,LCORL
prerank,CARD domain binding (GO:0050700),0.24568104770028332,0.5614675932467945,0.9311531841652324,1.0,1.0,2/14,8.84%,CARD10;IRGM
prerank,Hsp90 protein binding (GO:0051879),0.2139811098697944,0.5603431677063122,0.9667128987517337,1.0,1.0,6/33,16.12%,SLC12A2;NPAS2;HDAC6;AHSA1;ERN1;CHORDC1
prerank,ligand-gated anion channel activity (GO:0099095),0.239705919831887,0.5600423745761128,0.944078947368421,1.0,1.0,8/17,27.52%,GABRG2;GABRG1;GABRB3;GLRA3;GABRA3;GLRB;GABRG3;GABRA1
prerank,Toll-like receptor binding (GO:0035325),0.25872457946271665,0.5565565236982061,0.9473684210526315,1.0,1.0,11/11,74.15%,S100A9;TOLLIP;TIRAP;S100A8;TLR2;TLR1;DAB2IP;TLR6;CD36;UNC93B1;MYD88
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.2036552448799117,-0.5563015389498084,0.9603960396039604,0.9822692896915897,1.0,8/15,39.32%,P2RX7;P2RX4;GPR34;P2RY12;P2RY1;PTAFR;P2RX5;P2RX6
prerank,ATP hydrolysis activity (GO:0140603),0.20025362015624726,0.5520514003641669,0.9696132596685083,1.0,1.0,3/41,4.42%,KIF20B;CHD3;VWA8
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.2563394426311826,0.5495590847634105,0.9357638888888888,1.0,1.0,11/11,74.38%,CHRNA7;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNA9;CHRNB1;CHRNB2;CHRNA4
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.2591636712887148,0.5452178486153276,0.9525483304042179,1.0,1.0,2/10,11.18%,GABRG2;GABRG1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.245118701132892,0.5450725063581644,0.9380378657487092,1.0,1.0,7/13,27.52%,GABRG2;GABRG1;GLRA3;GABRA3;GLRB;GABRG3;GABRA1
prerank,disordered domain specific binding (GO:0097718),0.2179298078216495,0.5394402968436331,0.9682299546142209,1.0,1.0,3/23,12.16%,FN1;DFFB;NCOA3
prerank,cardiolipin binding (GO:1901612),0.24768875265532836,0.5340418514789448,0.9651567944250871,1.0,1.0,4/10,23.47%,MME;GSDMD;STOML2;UQCC3
prerank,N-methyltransferase activity (GO:0008170),0.209635930062736,0.5194942637017111,0.9698890649762282,1.0,1.0,6/20,22.37%,TFB2M;METTL5;TRMT1L;TRMO;TFB1M;TRMT1
prerank,neuropeptide hormone activity (GO:0005184),0.20721060234909883,0.5152420377845369,0.9741641337386018,1.0,1.0,22/22,79.31%,HCRT;AGRP;ADCYAP1;NPFF;PPY;CCK;NPY;OXT;CORT;QRFP;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;NMB;PNOC;GRP;SPX;PENK
prerank,DNA replication origin binding (GO:0003688),0.2024719372170706,0.5122347455658315,0.9803328290468987,1.0,1.0,8/23,24.81%,ORC5;ORC3;CDC6;ORC1;DHX9;DDX11;MCM4;ORC4
prerank,delayed rectifier potassium channel activity (GO:0005251),0.19231493926953797,0.5076153384925834,0.9912023460410557,1.0,1.0,1/32,1.84%,KCNA5
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.21817629186816026,0.504675195784012,0.9725806451612903,1.0,1.0,8/17,25.96%,DECR2;DHCR24;DECR1;BLVRA;PECR;MECR;PTGR1;PTGR2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.19678977968529032,0.503142892694185,0.9831804281345565,0.9997744310686418,1.0,2/26,7.11%,B3GALT1;EXTL2
prerank,signal sequence binding (GO:0005048),0.1843348773281894,0.49435199253461787,0.9824817518248176,0.9997995187196264,1.0,2/35,5.83%,KPNA7;KPNA2
prerank,histone methyltransferase activity (GO:0042054),-0.14654517517217747,-0.4853988732731916,0.9937888198757764,0.9958286213628984,1.0,16/32,40.95%,SMYD2;PRMT7;SUZ12;EED;FBL;EHMT2;SMYD3;TTLL12;KMT2E;NTMT1;EHMT1;SETD7;N6AMT1;CARM1;PRMT1;EZH2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.18513066919156448,0.48015242600246333,0.9864864864864865,1.0,1.0,2/30,9.42%,TNFAIP8;RPS6KA3
prerank,telomeric DNA binding (GO:0042162),0.1785320853962663,0.47539899939930397,0.9969924812030075,0.9994259039206913,1.0,11/32,28.08%,STN1;UPF2;SMG7;TERF2;XRCC6;HNRNPD;SMG6;RAD50;SMG5;RPA1;TERF2IP
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.17836223252309769,-0.47396835299723644,0.9974424552429667,0.993492941533135,1.0,8/15,48.69%,CMKLR1;CCR2;CCR9;GPR17;CCRL2;CCR1;ACKR4;CCR6
prerank,peptide N-acetyltransferase activity (GO:0034212),0.21729725787314388,0.4635591498695058,0.9858657243816255,0.9994581500223126,1.0,5/10,28.27%,NAA10;NAA60;NAA30;NAA20;NAA80
prerank,translation elongation factor activity (GO:0003746),0.20128851480907192,0.46076835489671,0.9850746268656716,0.9976238662848677,1.0,5/14,22.52%,EEFSEC;GTPBP1;GFM1;TSFM;GTPBP2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.20765554980877665,0.44873120196138394,0.9862778730703259,0.9972004989808956,1.0,2/12,15.65%,DHRS4;AIFM2
prerank,lysine N-methyltransferase activity (GO:0016278),0.1787570049003605,0.43529812710263316,0.9954682779456193,0.9966406328624472,1.0,6/20,22.65%,ATPSCKMT;SETD2;ETFBKMT;KMT5A;VCPKMT;EEF2KMT
prerank,phospholipase A2 activity (GO:0004623),0.15767274531433303,0.40269740695029865,0.9956331877729258,0.997434187668995,1.0,5/26,25.95%,PLAAT5;PNPLA8;PRDX6;PLA2G4A;PLA2G4C
